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Abstract  
Compared to photon radiation, proton radiation spares healthy tissue by better targeting the 
tumor, reducing entrance dose, and eliminating exit dose (Semenova, 2009). Research thus far 
has largely focused on intelligence and adaptive profiles for individuals treated with proton 
radiation therapy (PRT; Patel, Mullins, O-Neil, & Wilson, 2011). Additionally, the effect of age 
varies in regard to age being protective or not (Levisohn, Cronin-Golomb, & Schmahmann, 
2000; De Ruiter, Van Mourik, Schouten-Van Meeteren, Grootenhus, & Oosterlann, 2013; Wolfe, 
Madan-Swain, & Kana, 2012). This study aimed to retrospectively evaluate the effect of age on 
diagnosis on neuropsychological functioning for individuals with infratentorial tumors treated 
with PRT. Archival data from the Children’s Hospital of Philadelphia (CHOP) was used. A total 
of 24 participants were eligible to participate in the current study. A descriptive approach was 
used to describe the group’s performance because of the small sample size. A variety of 
measures were used to assess verbal and nonverbal cognitive skills, processing speed, verbal and 
visual memory, visual-motor/motor skills, and attention and inhibition abilities. Verbal 
comprehension and perceptual reasoning were found to be largely intact across all groups. 
Processing speed and visual-motor integration skills were Low Average, and dominant-hand 
fine-motor skills were Impaired. All other domains varied tremendously.  Potential explanations 
of the current findings are discussed. The primary limitations of this study are its small sample 
size and limited generalizability. More longitudinal research is needed to fully understand the 
impact of PRT on survivors of pediatric brain tumors.  Lastly, directions for future research are 
also discussed.  
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 Chapter 1: Statement of the Problem 
Pediatric brain tumors (PBTs) are the most common solid tumor in children 
(Poussaint, Panigraphy, & Huisman, 2015; Segal & Karajannis, 2016).  Approximately 
5.3 per 100,000 cases of brain and central nervous system (CNS) tumors are seen in 
children 0 to 19 years old each year (Poussaint et al., 2015). About 60% of childhood 
brain tumors originate in the infratentorium, which comprises the cerebellum, fourth 
ventricle, and brainstem and is usually referred to as the posterior fossa (Patel, Mullins, 
O’Neil, & Wilson, 2011; Ullrich & Pomeroy, 2003). Common infratentorial tumors are 
medulloblastoma, astrocytoma, ependymoma, and brainstem gliomas. Depending on the 
exact location, tumors in this region can be associated with hydrocephalus, resulting in 
headaches, vomiting upon awakening, and drowsiness as the tumor grows and puts 
pressure on the cortex and impedes flow of cerebrospinal fluid (Fleming & Chi, 2012; 
Mulhern & Palmer, 2003; Poussaint et al., 2015; Segal & Karajannis, 2016; Shiminski-
Maher & Shields, 1995).  Dizziness, problems with coordination, difficulty walking, and 
visual problems, such as double vision, involuntary jerky movements of eyes, and 
estropia (i.e., inward turning of one eye), are also experienced as results of the function of 
those brain areas associated with infratentorial tumors (Poussaint et al., 2015).  
Treatment of PBTs usually includes surgical resection of the tumor, 
chemotherapy, and/or radiation therapy. Depending on the location of the tumor, surgical 
removal may be difficult. Resection can result in neurological damage (De Ruiter et al., 
2013).  Chemotherapy is also used to treat PBTs and works by inducing DNA damage 
and apoptosis in cancer cells (Karajannis, Allen, & Newcomb, 2008).  For brain tumors 
that can disseminate throughout the CNS via cerebrospinal fluid, intrathecal 
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chemotherapy may be used, as it can cross the blood-brain barrier (Kerr, Berg, & Blaney, 
2001; Ullrich & Pomeroy, 2003).  Commonly, a combination of chemotherapy drugs is 
used, increasing the likelihood of destroying a higher number of tumor cells (Ullrich & 
Pomeroy, 2003).  In addition to chemotherapy, radiation may be administered to destroy 
any remaining tumor cells (Ullrich & Pomeroy, 2003). Radiation can be delivered to the 
entire CNS axis (i.e., craniospinal; whole brain and spine) with a “boost” (i.e., 
concentrated and localized amount to the tumor bed) or focal (i.e., focused only on the 
area of the tumor; Semenova, 2009).  
Radiation therapy (RT) works by damaging cell DNA resulting from free radical 
generation from ionization events (Cotter, McBride, & Yock, 2012). Additionally, cranial 
RT may disrupt the development of dendritic connections that occur during brain 
development and possibly disrupt myelin growth around nerve cells in the brain (Patel et 
al., 2011). When photon radiation is given, all areas of the brain affected by the radiation 
beam have the potential to be damaged (Semenova, 2009). Short-term side effects of 
cranial RT include loss of appetite, nausea, difficulty swallowing, fatigue, sore throat, 
and hair loss in the path of the radiation.  Cranial radiation can also have long-term 
effects on the hypothalamus and pituitary gland, which help regulate hormones for bodily 
function and growth (Chintagumpala & Gajjar, 2015). Disruption in these pathways can 
lead to obesity, short stature, scoliosis, and hypothyroidism. Additionally, cranial RT puts 
the individual at increased risk for secondary cancers, such as meningioma, acute 
lymphoblastic leukemia, and glioblastoma (Fossati, Richardi, & Orecchia, 2009).  
Cognitive deficits, such as problems with attention and memory and an overall 
decrease in intellectual ability, are also potential long-term effects of photon radiation. 
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Factors affecting the magnitude of deficits seen after treatment include tumor type, tumor 
location, time since treatment, and age (Patel et al., 2011). Although brain damage related 
to RT gradually emerges and can continue for several years, late cognitive effects, such 
as attention, executive functioning, and processing speed deficits, are typically seen 
within 1 to 2 years after treatment (Mulhern & Palmer, 2003; Patel et al., 2011). 
To reduce the possibility of damage to healthy brain tissue, focused radiation, 
specifically proton radiation therapy (PRT), has been implemented more recently. The 
biologic effect of PRT is theorized to be identical to that of photons used in conventional 
RT. Photon-based RT consists of high-energy electromagnetic waves. These waves 
penetrate tissue and deliver RT along the beam path. Dose delivery is greatest just below 
the skin and continues along the entire treatment path, eventually exiting the body. 
Therefore, RT is introduced to tissue both proximal and distal to the tumor (Cotter et al., 
2012). PRT is different in that it consists of charged particles with mass, which allows a 
small amount of energy to be deposited along the path until it reaches a maximum 
penetration depth. When the PRT particles reach the maximum depth, the remaining 
energy falls rapidly over a short distance, which is referred to as the Bragg Peak (Cotter 
et al., 2012). Therefore, PRT can control tumor growth and lower the risks of tumor 
recurrence because it is more controlled and localized than photon-based RT (Semenova, 
2009). Currently, 25 proton centers are in the United States, with 11 more in production 
(The National Association for Proton Therapy, 2018). Because PRT is a relatively new 
advancement, the literature associated with its long-term neuropsychological effects is 
sparse, and studies largely focus on cognitive abilities, attention, and memory (Antonini 
et al., 2017; Jimenez et al., 2013; Pulsifer et al., 2015; Ventura et al., 2018; Zureick et al., 
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2018). Therefore, more investigation is needed to fully understand the effect of PRT on 
neuropsychological functioning.  
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Chapter 2: Literature Review  
 
Pediatric Brain Tumors 
 Pediatric brain tumors (PBTs) are the most common solid tumor in children, and 
the second most prevalent cancer diagnosis in childhood (Poussaint et al., 2015). 
Between 2006 and 2010, an estimated 7% of all brain tumors reported in the United 
States were diagnosed in individuals younger than 20 years old (Poussaint et al., 2015).  
Approximately 5.3 per 100,000 cases of brain tumor and central nervous system (CNS) 
tumors are seen in children 0 to 19 years old each year (Poussaint et al., 2015). Although 
survival rates vary by tumor type, the overall 5-year survival rate for children with 
malignant and nonmalignant brain/CNS tumors aged 0 to 19 years is estimated to be 
73.9%. Survival after a diagnosis of a nonmalignant brain or other CNS tumor is 90.47% 
(Surveillance Epidemiology and End Results (SEER) Program, 2016). PBTs account for 
the most cancer deaths in children.  
Aggressiveness of a tumor is described by the World Health Organization (WHO) 
grading system based on histological characteristics. There are four grades – I, II, III, 
and IV. Grade I tumors are the least malignant and are usually associated with long-term 
survival rates. These tumors grow slowly, and surgery alone may be an effective 
treatment (Louis et al., 2007). Grade II tumors are slow growing; these tumors can spread 
into normal tissue nearby. Grade II tumors can also recur, and if recurrence happens, the 
tumor sometimes recurs as a higher-grade tumor (Louis et al., 2007). Grade III tumors are 
malignant tumors.  Grade IV tumors are the most malignant tumors; they rapidly 
reproduce and easily grow into nearby tissue (Louis et al., 2007).  Overall, WHO grading 
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has been used to predict response to outcome and treatment modalities. Now, new staging 
models are based on new information, including molecular genetics.  
PBTs can be divided into two categories, supratentorial and infratentorial tumors. 
The tentorium, an extension of the dura mater that separates the cerebellum from the 
occipital bone, separates these two locations (American Brain Tumor Association 
[ABTA], 2014). The supratentorium involves the area above the tentorium and contains 
the diencephalon and cerebrum, while areas below the tentorium include the cerebellum, 
fourth ventricle, and brainstem, composing the posterior fossa (ABTA, 2014). 
Supratentorial tumors are most commonly found among toddlers aged 2 to 3 years, while 
infratentorial tumors are the most common for those aged 4 to 10 years (Poussaint et al., 
2015). Supratentorial and infratentorial tumors occur at equal frequency in children 10 
years and older (Poussaint et al., 2015). Medulloblastoma is the most common 
infratentorial tumor, followed by cerebellar astrocytoma, brainstem glioma, and 
ependymoma (Chintagumpala & Gajjar, 2015). 
Although sporadic, two factors are linked to increased risk of developing a CNS 
tumor in childhood: prior radiation exposure and genetic syndromes (Fleming & Chi, 
2012). Prior radiation exposure increases the risk for developing a second malignancy, 
which can occur many years or even decades after treatment. In terms of genetic 
syndromes, varieties have been associated with CNS tumors. One such syndrome, 
neurofibromatosis type I (NF-1), involves the mutation of neurofibromin gene on 
Chromosome 17, and approximately 15% of individuals with NF-1 will develop a glial 
tumor of the optic tract and/or other tumors involving the CNS (Fleming & Chi, 2012). 
Tuberous Sclerosis, an autosomal-dominant disorder linked to genes related to 
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Chromosomes 9 and 16, has been linked to a low-grade brain tumor, subependymal giant 
cell astrocytoma, and malignant gliomas. Von Hippel Lindau (VHL), a systemic disorder 
associated with mutation of the VHL gene on Chromosome 3, has been associated with 
hamartomatous lesions, leading to hemangioblastomas, which can arise anywhere in the 
CNS (Fleming & Chi, 2012) 
Familial cancer predisposition syndromes, such as Li-Fraumeni syndrome, are 
also associated with an increased likelihood of developing a CNS tumor. Li-Fraumeni 
syndrome involves a mutation on the tumor suppressor gene on Chromosome 17. This 
mutation correlates with higher incidence of solid tumors, brain tumors, and cancer in 
younger people in families. Other syndromes associated with increased likelihood of 
CNS tumors include Gorlin syndrome and Turcot syndrome.  Gorlin syndrome puts 
individuals at a high risk for developing medulloblastoma, and Turcot syndrome is 
associated with an increased risk for brain (i.e., glioma and medulloblastoma) and colon 
cancer (Fleming & Chi, 2012).  
Typical Infratentorial Tumors 
Medulloblastoma  
Medulloblastoma is the most common malignant brain tumor in children (Bartlett, 
Kortmann, & Saran, 2013; Brandão & Poussaint, 2017; Chintagumpala & Gajjar, 2015; 
Segal & Karajannis, 2016; Wells & Packer, 2015). It is very invasive and tends to 
metastasize (Poretti, Meoded, & Huisman, 2012). Pathologically, it is classified as an 
embryonal tumor, which has a tendency toward rapid growth and spreading through the 
cerebrospinal fluid (Brandão & Young, 2017; Segal & Karajannis, 2016). Approximately 
20% of PBTs are categorized as medulloblastoma for those 0 to 14 years of age, and 
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incidence usually peaks between 3 and 4 years of age and again between 8 and 10 years 
of age, with the median age of onset between 5 to 7 years of age (Bartlett et al., 2013; 
Chintagumpala & Gajjar, 2015; Wells & Packer, 2015). Additionally, there is a slight 
male preponderance (Bartlett et al., 2013; Brandão & Poussaint, 2017).  
Advances in molecular genetics have resulted in classifying medulloblastoma into 
four groups: WNT, SHH (Sonic Hedgehog), Group 3, and Group 4. WNT subgroup 
tumors are named for the WNT signaling pathway, and make up approximately 10% of 
individuals diagnosed with a medulloblastoma. These tumors do not tend to metastasize 
and usually are located in the midline of the cerebellum and, therefore, have a 5-year 
survival rate of greater than 90%. A mutation results in dysregulation of WNT for this 
subgroup. SHH subgroup tumors comprise about 25% of medulloblastomas. These 
tumors usually do not metastasize and are usually located in the cerebellar hemispheres. 
These tumors result in far poorer prognosis in comparison to WNT subgroup tumors. 
These tumors result from mutations at one of the several points in the SHH signaling 
pathway and can be associated with Li-Fraumeni syndrome. The Group 3 subgroup 
tumors also include 25% of medulloblastoma diagnoses and are often disseminated at 
diagnosis. This subgroup is associated with many different mutations and the worst 
prognosis. Finally, Group 4 tumors are associated with intermediate prognosis compared 
to the other subtypes, with the exception of in infants, who have poor survival rates, and 
make up approximately 35% of medulloblastomas. The genetic alterations are very 
complex for this group (Segal & Karajannis, 2016).  
Most symptoms related to medulloblastoma stem from hydrocephalus (the 
obstruction of cerebrospinal fluid pathways), as well as involvement of the brainstem or 
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cerebellum (Bartlett et al., 2013; Chintagumpala & Gajjar, 2015; Millard & De Braganca, 
2016; Wells & Packer, 2015).  Raised intracranial pressure can lead to headache and 
vomiting, and unsteadiness is usually present in about 50 to 80% of those diagnosed with 
medulloblastoma (Bartlett et al., 2013; Chintagumpala & Gajjar, 2015; Millard & De 
Braganca, 2016; Quinlan & Rizzolo, 2017). Symptoms more common in infants include 
unexplained lethargy, head tilt, and macrocephaly (Chintagumpala & Gajjar, 2015). 
Cranial-nerve involvement may be seen as well (Millard & De Braganca, 2016).  Owing 
to rapid rate of tumor growth and subsequent symptom severity, 50 to 75% of individuals 
report symptoms fewer than 12 weeks before diagnosis (Bartlett et al., 2013). The median 
onset of symptoms to diagnosis is 65 days (Quinlan & Rizzolo, 2017).  
Medulloblastoma tumors are usually categorized as average risk or high risk. 
Absence of metastases and gross total resection or near total resection lead to a 
categorization of average risk. If residual tumor is greater than 1.5cm2 or metastasis is 
evident, the tumor is categorized as high risk (Chintagumpala & Gajjar, 2015; Millard & 
De Braganca, 2016). 
The treatment of medulloblastoma includes surgery, radiation, and chemotherapy. 
Surgery is used to resect the tumor, as well as to restore flow of cerebrospinal fluid if 
obstructive hydrocephalus is observed (Bartlett et al., 2013). About 50% of individuals 
require the insertion of a shunt at the time of surgery or shortly thereafter. A complication 
seen in individuals who go through surgery for medulloblastoma is posterior fossa 
syndrome (PFS). The incidence of PFS for those survivors of medulloblastoma ranges 
greatly, with some research stating 25% of survivors and other research stating as many 
as 40% of survivors (Bartlett et al., 2013; Segal & Karajannis, 2016). Korah et al. (2010) 
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reported an incidence of approximately 25% using data from The Children’s Oncology 
Group. The onset of PFS is usually 24 to 48 hours after surgery and can take months to 
resolve. Symptoms include truncal ataxia, mutism, emotional lability, and difficulty 
swallowing (Bartlett et al., 2013; Millard & De Braganca, 2016).  
A probability exists for medulloblastoma to disseminate via cerebrospinal fluid, 
so current practice includes craniospinal radiation with a boost to the posterior fossa or 
tumor bed (Bartlett et al., 2013; Cotter et al., 2012; Wells & Packer, 2015). In addition to 
radiation, adjuvant chemotherapy is used for most patients, with a combination of 
chemotherapy drugs resulting in the best outcomes (Wells & Packer, 2015). Additionally, 
chemotherapy can be used to delay radiation treatment in very young individuals (Cotter 
et al., 2012). Furthermore, high-dose chemotherapy with adjuvant stem cell rescue is used 
for individuals with high-risk disease and with younger children (Altshuler et al., 2016).  
Glial Neoplasms  
Glial neoplasms “glioma” is used to describe any tumor arising from the glial 
cells in the brain. The three types of glial cells are astrocytes, ependymal, and 
oligodendrocyte, which lead to astrocytoma, ependymoma, and oligodendroglioma 
tumors, respectively (ABTA, 2014; Yachnis, 1997).  
Astrocytoma. Approximately 20 to 35% of cerebellar astrocytoma present in the 
posterior fossa, and approximately 80% of these tumors are juvenile pilocytic 
astrocytoma, WHO Grade I, and 15% are WHO Grade II (Brandão & Poussaint, 2017; 
Mueller & Chang, 2009). Overall, low-grade astrocytoma have very good prognosis, with 
5-year survival rates of 80 to 90% (Bian, McAleer, Vats, Mahajan, & Grosshans., 2013; 
Brandão & Poussaint, 2017; Mueller & Chang, 2009). Causes of astrocytoma are unclear, 
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but individuals with some genetic disorders, such as Li-Fraumeni syndrome or NF-1, 
carry a high risk of developing this type of tumor (Mueller & Chang, 2009). Furthermore, 
a known risk factor includes prior radiation (Mueller & Chang, 2009).  
Most low-grade astrocytomas are diagnosed in children younger than 10 years 
old, with peak incidence between 6 and 8 years old (Bonfield & Steinbok, 2015). 
Pilocytic astrocytoma is a benign tumor that produces symptoms that are generally long 
standing, with nearly half of patients having active symptoms for longer than 6 months at 
time of diagnosis (Bonfield & Steinbok, 2015). Because of the tumor’s slow growth rate, 
the pediatric brain is able to compensate, often leading to a very large tumor at the time 
of diagnosis (Bonfield & Steinbok, 2015). Symptoms include increased intracranial 
pressure caused by hydrocephalus, which also leads to headache. Headache is the most 
common symptom seen in this population; the headache tends to worsen with exertion, 
and may be at its worst upon waking (Bonfield & Steinbok, 2015).  The cerebrospinal 
fluid is obstructed at the level of the fourth ventricle aqueduct, leading to hydrocephalus 
in 90% of cases (Bonfield & Steinbok, 2015).  Other symptoms related to hydrocephalus 
include lethargy and vomiting, as well as sixth cranial nerve palsy, increased head 
circumference, or upgaze restriction, all of which are seen less frequently (Bonfield & 
Steinbok, 2015). Owing to the location of the tumor, ataxia, dysmetria (i.e., lack of 
movement coordination), and horizontal nystagmus (i.e., rapid eye movement) can also 
be seen (Bonfield & Steinbok, 2015).   
Individuals diagnosed with low-grade astrocytoma have a good prognosis because 
they are often curable; radiation therapy plays an integral role in survival rates 
(Greenberger et al., 2014). Surgery to resect the tumor is the first intervention used, and 
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low morbidity is possible when total resection is accomplished. However, because these 
tumors are close to critical brain structures, many individuals can undergo only partial 
resection, leading to possible issues, such as recurrence (Greenberger et al., 2014).  
Brainstem glioma. Brainstem glioma is the third most common infratentorial 
tumor in children, with very poor long-term survival. Approximately 6 to 10% survive 
beyond 2 years of diagnosis (Mueller & Chang, 2009). Although these tumors can be 
focal, they tend to be diffuse, thus correlating with a poorer prognosis. Overall, these 
tumors are highly malignant and tend to have poor response to treatment (Shiminski-
Maher & Shields, 1995). This tumor can extend from the pons upward into the midbrain, 
and then down into the medulla. Individuals with brainstem glioma may present with 
multiple cranial nerve palsies and hemiparesis (Shiminski-Maher & Shields, 1995). 
Brainstem gliomas are a type of astrocytoma and can be classified into three main groups. 
The largest subgroup is diffuse, intrinsic pontine glioma. This type carries the worst 
prognosis of any brain tumor in children, with the median survival of less than 1 year 
(Ramos et al., 2013). Age at onset is usually between 5 to 10 years old. These types of 
tumors are usually malignant (Grade III or IV), and surgery has no therapeutic role. The 
current recommendation is focal radiation therapy, with disappointing chemotherapy 
results (Ramos et al., 2013).   
The second subgroup is composed of slow-growing, low-grade tumors arising 
from the cervicomedullary junction of the floor of the fourth ventricle. Prognosis of this 
type is much better, with median survival being longer than 5 years (Ramos et al., 2013).  
A long duration of symptoms is often seen before diagnosis, and histology often reveals a 
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pilocytic astrocytoma. Long-term survival or complete remission is possible (Ramos et 
al., 2013).  
The third subgroup, indolent, focal, tectal gliomas, are often diagnosed with 
preceding hydrocephalus and increased intracranial pressure. These tumors are well-
defined, low-grade astrocytoma with good prognosis. Surgery is often recommended and 
can be the only form of treatment for this type of tumor (Ramos et al., 2013).  
Ependymoma. Ependymoma accounts for approximately 10% of brain tumors in 
children (Cage et al., 2013; Chintagumpala & Gajjar, 2015; Venkatramani et al., 2013). 
As many as two thirds of these tumors occur in the posterior fossa, with a ratio of male to 
female individuals of 1.3:2.0 (Antony et al., 2014; Cage et al., 2013; Chintagumpala & 
Gajjar, 2015; Venkatramani et al., 2013). The two peaks of incidence are in the first 7 
years of life and in the third to fifth decades of life (Brandão & Poussaint, 2017; 
Chintagumpala & Gajjar, 2015). The majority (20-51%) of individuals diagnosed with 
ependymoma are younger than the age of 3 years (Cotter et al., 2012; Sato et al., 2017). 
As stated earlier, ependymomas are the fourth most common posterior fossa tumor 
(Brandão & Poussaint, 2017; Wells & Packer, 2015). These tumors are slowly growing 
glial tumors that arise from the ependymal lining of the ventricular system, especially the 
fourth ventricle (Cotter et al., 2012; McGuire, Sainani, & Fisher, 2009; Shiminski & 
Shields, 1995) Radial glial cells are postulated to be the cell of origin (Wu, Armstrong, & 
Gilbert, 2016).  
Ependymoma tumors that are WHO Grade III have been shown to have a 
correlation between anaplastic histology, a higher rate of recurrence (ranging from 20-
49%), and significant mortality rates (Antony et al., 2014; Chintagumpala & Gajjar, 
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2015; McGuire et al., 2009). Ten-year survival rates have ranged from 45 to 75% 
(Swanson et al., 2011). The standard of care remains surgical resection followed by 
radiation to the tumor site (Antony et al., 2014). Total resection has been associated with 
a survival rate of 66 to 75%, while subtotal resection has been associated with a survival 
rate of 0 to 11% (Segal & Karajannis, 2016). However, gross total resection may be 
difficult, especially for tumors in the posterior fossa. Focal radiation is recommended 
rather than whole-brain or craniospinal radiation unless dissemination of the tumor is 
seen (Wu et al., 2016). For incomplete resection and for children too young for radiation, 
chemotherapy is used as well (Antony et al., 2014). However, those undergoing 
chemotherapy as the only treatment modality have a higher risk of poor outcomes, 
including increased mortality, morbidity, and tumor progression (Cage et al., 2013; 
Cotter et al., 2012; Segal & Karajannis, 2016; Venkatramani et al., 2013).  
About 80% of ependymomas originate in the infratentorial region, and distinct 
genomic structures differentiate supratentorial and infratentorial ependymoma 
(Charalambides, Dinopoulos, & Sgouros, 2009; Wu et al., 2016). Ependymomas found in 
the supratentorium have superior outcomes compared with those located in the 
infratentorium, possibly because gross total resection is better accomplished in the 
supratentorium (Antony et al., 2014).  In regard to ependymoma found in the posterior 
fossa, two types of distinct subgroups have been designated that are demographically, 
genetically, and clinically different. Posterior Fossa, Group A (PFA) occurs 
predominantly in infants and is located laterally in the posterior fossa; this type is 
associated with poor clinical prognosis. Posterior fossa, Group B (PFB) usually occurs in 
older children and adults and is associated with a better prognosis. The upregulation of 
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many cancer-related pathways were observed between these two types, further explaining 
the two distinct groups (Segal & Karajannis, 2016; Wu et al., 2016). 
Treatment of Pediatric Brain Tumors 
Surgery and Its Consequences  
Surgical resection is usually the first step in treating PBTs (Catsman-Berrevoets 
& Aarsen, 2010). Because the extent of resection is seen as a predictor of outcome for 
infratentorial tumors, the existing treatment regimen involves aggressive surgical removal 
(Korah et al., 2010). However, aggressive resection is controversial. More recent reports 
suggest that subtotal resection followed by RT can produce outcomes superior to 
aggressive surgery alone (Bishop et al., 2014).  
When an individual goes through gross total or partial resection, PFS may result 
(Catsman-Berrevoets & Aarsen, 2010).  Although the mechanism of PFS is poorly 
understood, decreased blood flow following surgery has been hypothesized as the 
potential cause (Catsman-Berrevoets & Aarsen, 2010; Korah et al., 2010). Additionally, 
disruption in the pathways extending from the cerebellum that communicate with the 
cerebral hemispheres is also posited as a potential cause (Reed-Berendt et al., 2014).  
Risk factors for PFS have been studied with varying levels of consensus. Midline 
location of the tumor with brainstem invasion or compression has been consistently 
reported as a risk factor (Avula, Mallucci, Kumar, & Pizer, 2015; Korah et al., 2010). 
Younger age has also been reported as a predictor of PFS (Korah et al., 2010). 
Medulloblastomas have the highest risk of PFS compared to other posterior fossa  
tumors. Overall, extent of surgical resection has been an important factor in development 
of PFS (Avula et al., 2015). In a review by Reed-Berendt et al. (2014), the authors stated 
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that studies focused on PFS have much variability in the collection of data, making an 
understanding of the etiology difficult, and indicated that PFS is unpredictable in etiology 
and severity.  
 Symptoms of PFS include impaired eye opening or decreased spontaneous 
initiation of movements (Catsman-Berrevoets & Aarsen, 2010). Mutism is the main 
characteristic of PFS; it can occur shortly after resection or can be delayed several days 
post surgery (Avula et al., 2015; Catsman-Berrevoets & Aarsen, 2010; Segal & 
Karajannis, 2016). Mutism can last between 1 day to 6 months, or beyond (Avula et al., 
2015; Korah et al., 2010). Dysarthria usually follows mutism during the recovery period. 
Although the symptoms of PFS tend to improve with time, such deficits as dysarthria and 
neurocognitive difficulties (i.e., IQ abilities, visual-spatial deficits, executive-function 
impairments) can be seen long term (Avula et al., 2015; Charalambides et al., 2009). 
Other symptoms of PFS include vision problems, difficulty swallowing, mood effects, 
and gross- and fine-motor difficulties. In a study by Korah et al. (2010), participants 
affected by PFS were 2.4 years younger than those not affected by the syndrome. The 
authors postulated that the development of language and motor systems in younger 
children makes them more vulnerable to this complication (Korah et al., 2010). Along 
with mutism, language and other neurocognitive deficits were seen in a significant 
proportion of patients beyond 1year post surgery, with 78% showing incomplete recovery 
at follow-up (Korah et al., 2010).  
Overall, individuals treated with surgery only have been shown to have difficulty 
with verbal memory skills, executive function, visual-spatial abilities, and expressive 
language for those with posterior fossa tumors (Levisohn, Cronin-Golomb, & 
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Schmahmann, 2000; Schmahmann & Sherman, 1998).  Individuals also have difficulty 
with story memory tests, with most being able to recall only a few details (Levisohn et 
al., 2000).  Surgery only treatment could also be associated with personality, emotional 
changes, and difficulty with modulation of affect (Schmahmann & Sherman, 1998).   
Studies have found cognitive deficits following resection of posterior fossa 
tumors, suggesting the tumor or surgical resection is responsible for deficits (De Ruiter et 
al., 2013; Levisohn et al., 2000; Mabbott, Penkman, Witol, Strother, & Bouffet, 2008). 
The cerebellum has been associated with motor and coordination skills and has a role in 
cognitive and executive functioning as a result of the feed forward and feedback routes 
that have been established between the cerebellum and the cortex (Hanzlik, Woodrome, 
Abdel-Baki, Geller, & Elbabaa., 2015; Lassaletta, Bouffet, Mabbott, & Kulkarni, 2015). 
Therefore, the cerebellum plays an important role in higher order functioning in addition 
to motor functioning because of the reciprocal connections with the frontal lobes 
(Charalambides et al., 2009; Di Rocco et al., 2010; Lassaletta et al., 2015; Mabbott et al., 
2008; Varela, Liakopoulou, Alexiou, Pitsouni, & Alevizopoulos., 2011).  
Perioperative and operative factors, such as hydrocephalus or shunt infections, 
have been associated with both reduced FSIQ and verbal IQ scores, as well as with 
neurological deficits, such as reduced hand skill and oculomotor deficits (Fossati et al., 
2009). Fossati et al. (2009) stated that studies have shown that patients’ presurgery IQ 
was lower than average, especially relevant in younger patients. Therefore, the authors 
suggested that the tumor itself may cause a decrease in cognitive functioning prior to 
receiving any treatment. IQ decline was more relevant for younger patients and was less 
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evident in patients receiving surgery without radiation, although the exact age range is 
unknown. 
Chemotherapy and Its Consequences  
Chemotherapy can be used as the only treatment modality, especially with very 
young children (Nelson, Compton, Patel, Jacob, & Harper, 2013). Between the ages of 5 
to 7 years and beyond, periods of myelination of axons and multiplication of glial cells 
occur. This development can be interrupted with the introduction of radiation or 
chemotherapy. If an individual is receiving treatment at a critical period in which rapid 
brain growth is occurring, less of an insult or interruption is needed to make a dramatic, 
lasting effect (Nelson et al., 2013).  
Since 1991, three sequential prospective clinical trials have been conducted by the 
“Head Start” Consortium for very young children diagnosed with a malignant CNS tumor 
(Altshuler et al., 2016). The Consortium is currently on the fourth phase of this protocol. 
These trials sought to improve the cure rate with the use of chemotherapy and stem cell 
treatment while delaying RT. Atschuler et al. (2016) reviewed the three consecutive 
trials, which included a total of 226 children. Results showed a decrease in morbidity and 
mortality and improved overall survival over time in comparing the three protocols to 
each other.  
Meta-analytic studies have focused on the impact of chemotherapy for survivors 
of childhood cancer (Pierson, Waite, & Pyykkonen, 2016). In reviewing a total of 18 
studies, attention was found to be the only area of functioning that was different 
compared to normative data. This finding was related to chemotherapy’s effect on white-
matter networks within the frontostriatal regions of the brain. No differences were found 
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in regard to global intelligence, both verbal and nonverbal. Moderation analyses were 
completed, and age was not found to be a significant predictor of deficits, but time since 
treatment completion was significant. Greater impairment in regard to attention was 
found for those within 5 years versus those 5 or more years since treatment completion 
(Pierson et al., 2016). Reasons for this discrepancy were hypothesized to be differences in 
treatment and the small number of studies used in the moderator analyses.  
 Additionally, Nelson et al. (2013) reported no significant loss of IQ points in 
patients after chemotherapy in comparison to those treated with radiation in their sample. 
Additionally, those individuals treated before the age of 3 years showed IQ and memory 
scores within the average range overall (Nelson et al., 2013).    
Radiation Therapy and Its Consequences  
Radiation can be introduced in a few different ways. Craniospinal RT treats the 
craniospinal axis, targeting both the spine and cortex, and is used best for tumors known 
to spread, such as medulloblastoma (Hoffman & Yock, 2009). Whole-ventricle RT 
targets ventricles, and focal RT targets a specific area. Additionally, although RT can be 
delivered in a variety of forms, fractionated external beam is used often for PBTs (Bindra 
& Wolden, 2016). A “boost” (i.e., a concentrated and localized amount of RT to the 
tumor bed) can also be used (Semenova, 2009). The patient typically receives 20 to 33 
small fractions of RT over the course of 4 to 7 weeks. When individuals receive RT, they 
must lie completely still so that the RT beam targets the correct location. Therefore, 
younger children may require anesthesia to ensure little movement. Treatments can last 
approximately 15 minutes for focal targets and as long as 90 minutes for craniospinal 
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targets (Bindra & Wolden, 2016). The absorbed dose of radiation in tissue is measured in 
centigray (cGy), and typical doses for PBTs range from 3000 to 6000 cGy.   
 Intensity-modulated radiation therapy (IMRT) was developed in the 1980s and 
became widely used in the mid1990s. IMRT is photon based and allows the radiation 
beam to be divided into a large number of beams, each having a different direction 
(Bishop et al., 2014; Khuntia, Tomé & Mehta, 2009). The different beams can mimic the 
individual’s anatomy and thus improve radiation distributions. The radiation deposits 
energy in the tissue by ejecting electrons that interact with cancer cells (Hoffman & 
Yock, 2009). This energy deposit, along with using 3-D concave or convex 
configurations, allows for a dramatic reduction in high doses of radiation reaching 
healthy tissue (Khuntia et al., 2009). Additionally, IMRT allows for differential doses of 
radiation to the target. For example, a higher dose (i.e., boost) can be given to a place of 
higher recurrence, while the rest of the target can be treated at a conventional dose. 
However, this actually increases the low-dose radiation that reaches healthy tissue 
(Khuntia et al., 2009). IMRT has a risk of late injury to normal tissue caused by the lack 
of precision delivery. To reduce damage, radiation is given daily to encourage the normal 
tissue to repair itself prior to the next dose of radiation. Because the risk of healthy tissue 
receiving radiation is high, so is the long-term risk of second malignancies and 
pronounced neurocognitive deficits (De Ruiter et al., 2013 Khuntia et al., 2009; 
Semenova, 2009).  
Fossati et al. (2009) stated that studying the risk of second malignancies is 
difficult because of the long-term follow-up that is necessary (15 years or more).  The 
reason for second malignancies is not clear, nor is whether the recurrence is caused by 
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genetics that brought about the first cancer in the first place, but the cumulative risk of a 
second cancer varies from 1.7 to 13% (Fossati et al., 2009). In addition, 71% of those 
secondary tumors arose from within the edge of radiation fields (Fossati et al., 2009).  For 
those with a genetic syndrome, such as NF-1, the risk of secondary tumors increases 
(Fleming & Chi, 2012). Additionally, radiation necrosis is an occasional devastating side 
effect of RT thought to result from myriad processes, including a loss of myelin and a 
disruption of the blood-brain barrier (Sato et al., 2017).. Radiation necrosis typically 
develops between 6 months and 3 years after treatment with RT, with an incidence of 5 
to10% (Sato et al., 2017). Known risk factors include total radiation dose, treatment 
duration, and fraction size.  
RT has become the cornerstone of treatment for PBTs and has contributed to 5-
year survival rates of approximately 73.9% (Segal & Karajannis, 2016). However, as 
survivorship is increasing, so are neurocognitive deficits, ranging from global reduction 
of intelligence to problems in attention (Butler & Haser, 2006; Ellenberg et al., 2009; 
Kahalley et al., 2013). The decline in cognitive functioning is more evident in those 
receiving radiation to the posterior fossa and worse for those receiving craniospinal 
radiation (Brodin et al., 2013; Ellenberg et al., 2009; Fossati et al., 2009; Kahalley et al., 
2013; Mulhern & Butler, 2004; Robinson, Fraley, Pearson, Kuttesch, & Compas, 2013). 
Difficulty with abstract thinking, a more severe deficit, has been correlated with higher 
doses of radiation and younger age at treatment (Butler & Haser, 2006; Nelson et al., 
2013; Robinson et al., 2013). Of the three options for treatment of PBTs (i.e., surgery, 
chemotherapy, RT), RT is responsible for the greatest number of adverse effects, and the 
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combination of RT and chemotherapy results in greater long-term damage caused by their 
possible synergistic properties (De Ruiter et al., 2013; Semenova, 2009).   
In addition to neurocognitive effects associated with photon RT, endocrine, 
auditory, and vascular defects are also common. Endocrine deficits often lead to 
hypothyroidism, osteoporosis, and growth hormone deficiencies. A common side effect 
of chemotherapy, hearing loss can also occur when radiation reaches the cochlea at doses 
greater than 3500 to 4500 cGy (Cotter et al., 2012). Lastly, vascular risks have been 
associated with photon radiation. In particular, the risk of stroke is high for survivors of 
PBTs (Gondi, Yock, & Mehta, 2016).  The good news is that these deficits with 
conventional RT are reduced with the help of PRT (Gondi et al., 2016).  
Neuropsychological Deficits Associated with Radiation Therapy 
Overall, most studies investigating neuropsychological deficits following 
treatment for PBTs are retrospective and have limitations, such as small, heterogeneous 
samples. Additionally, posterior fossa tumors are usually grouped together despite 
varying treatment approaches and prognoses between tumors (Charalambides et al., 
2009). Ependymoma is the rarest type of tumor, so the fewest studies investigate this type 
of tumor, unfortunately. Most studies look at functioning following surgery or adjuvant 
therapy, making difficult a determination of whether deficits are caused by the tumor 
itself or by the interventions used. Obtaining data for individuals before undergoing 
treatment for their PBTs is difficult, and baseline assessments can be compromised even 
prior to the introduction of RT, which is evident in survivors who do not receive RT. 
Therefore, neurocognitive deficits have been postulated to be related to the tumor itself, 
or related to surgery, chemotherapy, and/or hydrocephalus (Cotter et al., 2012). 
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Di Rocco et al. (2010) described the variability in neuropsychological impairment 
already present at diagnosis for individuals diagnosed with a PBT. Cognitive deficits in 
the preoperative period were associated with brainstem infiltration, hydrocephalus, and a 
diagnosis of medulloblastoma. These deficits included difficulties in thinking and 
reduced verbal fluency. Language deficits were seen more frequently in individuals with 
tumors involving the right cerebellar hemisphere, which made sense because the right 
cerebellum participates in language as a result of the cross-connections with the left 
cerebral hemisphere (Di Rocco et al., 2010). The cerebellum has also been correlated 
with attention and executive function. Di Rocco et al. (2010) found that those in their 
study showed attention and executive functioning deficits prior to surgery. Procedural 
memory impairment was also seen for individuals who had an infiltrating brainstem 
tumor, but for the majority of the sample, this impairment improved post surgery. 
Additionally, a study conducted with individuals with posterior fossa astrocytoma found 
that participants were already impaired in memory, attention, and motor and visual spatial 
functioning at the time of diagnosis, suggesting a tumor effect rather than a treatment 
effect (Ater et al., 1996). 
Varela et al. (2011) also investigated presurgical neuropsychological functioning 
for individuals with posterior fossa tumors. In contrast to the findings of  Di Ricco et al. 
(2010), Varela et al. (2011) did not find a significant difference between their posterior 
fossa tumor group and a group of age-matched peers in regard to intelligence scores. In 
contrast, Thigpen et al. (2016) found that results of intellectual functioning were below 
the population mean in their study, but within the average range for their cohort of 49 
 NEUROPSYCHOLOGICAL FUNCTIONING FOR PBT SURVIVORS                    24 
 
individuals prior to surgery. However, approximately one third fell one or more standard 
deviations below the normative mean.  
Although the previously mentioned studies focused on pretreatment effects, the 
feasibility of obtaining these data prior to intervention for survivors of PBTs is difficult. 
Therefore, many of the studies are conducted post surgery, chemotherapy, and/or 
radiation. Additionally, the majority of meta-analyses focus upon two areas of 
functioning – intelligence and attention (De Ruiter et al., 2013).  
Intelligence 
 Multiple studies have investigated the impact of conventional RT on intelligence 
and largely have found a lower IQ score (1- 2 SDs below the mean) with a decrease of 2 
to 4 points per year (Palmer et al., 2003; Saury & Emanuelson, 2011; Spiegler, Bouffet, 
Greenberg, Rutka, & Mabbott, 2004). ). Even though intelligence is largely the focus of 
many studies, intelligence tests are relatively insensitive to specific neuropsychological 
impairments (Butler & Haser, 2006).  Nonetheless, meta-analytic studies report Low 
Average general intelligence post treatment, with the Perceptual Reasoning Index (PRI) 
and Verbal Comprehension Index (VCI) scores being significantly below average (De 
Ruiter et al., 2013). Furthermore, the PRI is usually more affected than the VCI, likely as 
a result of the tumor’s location (i.e., posterior fossa). Processing speed is also a domain 
frequently reported as an area affected by treatment for a posterior fossa tumor (Aukema 
et al., 2009; Mabbott et al., 2008; Ribi et al., 2005; Spiegler et al., 2004).  Researchers 
have postulated that PRI and processing speed are consistently affected by infratentorial 
PBTs, as these functions rely heavily on the cerebellum and  subtests comprising the PRI 
rely on motor functions, visual attention, working memory, visual motor integration, and 
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abstract reasoning (De Ruiter et al., 2013; Kahalley et al., 2013; Kahalley et al., 2014; 
Palmer et al., 2013).  
In terms of moderating variables, meta-analyses have shown that craniospinal RT 
has been a relevant risk factor for decline in neuropsychological functioning for survivors 
of PBTs (Butler et al., 2008; De Ruiter et al., 2013). Cranial RT leads to lower scores for 
FSIQ and PRI, but not for VCI, and longer time since diagnosis was associated with 
lower scores on all scales of intelligence (De Ruiter et al., 2013). However, no predictive 
value was found for tumor location for intelligence scores. Of note, an association 
between age at diagnosis and time since diagnosis was strong, making distinguishing 
between these moderating variables impossible (De Ruiter et al., 2013).  
Palmer et al. (2003) investigated moderating variables for survivors of 
medulloblastoma treated with craniospinal RT. Results found a significant linear decline 
in FSIQ of a decrease in 2.53 FSIQ points per year for the entire subset of patients aged 
from 2.26 to 15.76 years (N = 39). Those who were younger at diagnosis (M = 5.86 
years) were at higher risk for this decline when compared to those who were older at 
diagnosis (M = 11.05 years). The authors followed these patients for 7 years, and a 
decline in FSIQ was seen throughout those 7 years. Additionally, Palmer et al. (2003) 
found that participants who had higher IQ scores at baseline (i.e., > 94, n = 13) had a 
steeper decline in functioning compared to others in the group. The reasoning behind the 
decline was unknown; the authors suggested that children with different abilities are 
affected differently by treatment. This finding is in contrast to previous research that 
found that those with higher intelligence previous to treatment had fewer declines after 
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treatment than did those with lower intelligence. In order to examine reasoning behind 
this phenomenon, pre-morbid functioning is likely needed (Palmer et al., 2003).  
Fossati et al. (2009) reviewed various articles investigating the effect of radiation 
dose on IQ for survivors of posterior fossa tumors. They stated that the results were 
consistent in that all patients showed a decline in IQ after treatment (i.e., surgery and/or 
radiation). This decline was higher for survivors who were younger at time of treatment 
and the worst for those who had received craniospinal RT. The mean reported decline in 
FSIQ score for individuals treated for medulloblastoma was found to be 2.5 to 4.3 points 
per year (Fossati et al., 2009). Fossati et al. (2009) also reviewed a study by Grill et al. 
(1999). This study included 31 individuals treated for medulloblastoma; results showed 
that those receiving conventional RT to only the posterior fossa had a mean IQ score of 
84.5, while those receiving 2500 cGy craniospinal RT had a mean IQ of 76.9. Lastly, 
individuals who received 3500 cGy craniospinal RT had a mean IQ more than 2 standard 
deviations below the average (M = 63.7). Those individuals with craniospinal RT were 
also treated with radiation to the posterior fossa with a boost as great as 5500 cGy (as 
cited in Fossati et al., 2009).  
Hanzlik et al. (2015) also looked at three posterior fossa tumors, 
medulloblastoma, astrocytoma, and ependymoma, in a meta-analysis to investigate the 
neuropsychological outcomes for these tumors at least 3 years post treatment.  Their 
search found that survivors of medulloblastoma had worse outcomes when compared to 
those with astrocytoma and ependymoma, with survivors of astrocytoma having the most 
positive outcomes overall (Hanzlik et al., 2015).  In regard to cognitive functioning (i.e., 
IQ), survivors of astrocytoma reported scores in the normal range, while survivors of 
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medulloblastoma had scores greater than 1 standard deviation below the mean and a loss 
of IQ points as time elapsed since diagnosis. Some survivors of ependymoma showed 
declines in IQ, but the declines did not continue as time progressed (Hanzlik et al., 2015). 
Hanzlik and colleagues (2015) hypothesized that radiation modality was the reason for 
these discrepancies. Most of the survivors of astrocytoma were treated with surgery only, 
survivors of ependymoma received focal radiation, and survivors of medulloblastoma 
received craniospinal RT. Overall,the search by Hanzlik et al. (2015) showed that all 
three tumor types led to some cognitive deficits years after treatment.    
Because an IQ score is a composite of skills, researchers have hypothesized that 
the decline in overall IQ score is primarily because children treated with RT have slower 
acquisition of skills in relation to their healthy peers (Mabbott et al., 2008; Palmer et al., 
2013). Thus, the increasing gap between the scores of those with PBT and healthy, age-
matched peers leads to lower IQ scores for survivors of PBTs (Mabbott et al., 2008). 
Processing problems may arise when multiple demands are put upon the individual that 
involve complex mental operations because of the engagement of more widespread 
neural networks in the brain (De Ruiter et al., 2013; Reddick et al., 2003). Struggling to 
process information as quickly as their peers may lead survivors of PBTs to lag behind 
and increase the gap between their skills and knowledge compared to those of their 
healthy peers (Kahalley et al., 2013; Mabbott et al., 2008; Palmer et al., 2013). 
After RT, a loss of white matter (i.e., demyelination) occurs. Cortical white-
matter tracts normally complete myelination by 3 or 4 years of age in healthy individuals. 
However, myelination may be delayed with the presence of a tumor and/or radiation 
(Palmer et al., 2013).  Additionally, the newly synthesized myelin has higher metabolic 
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activity and lower stability, making it more vulnerable to the effects of radiation (Reddick 
et al., 2006). The myelination process in the frontal lobes, where executive functioning, 
planning/organizing, and attention are known to associate is completed last (Reddick et 
al., 2003). A review of the literature shows that demyelination after cranial radiation may 
appear within 5 months after treatment and continues to progress over time.  Loss of 
white matter and gray matter has been seen in children treated with both standard-dose 
chemotherapy and cranial radiation (Nelson et al., 2013; Reddick et al., 2006). 
Furthermore, research comparing survivors of PBTs to control groups found significant 
reduction in white-matter volume for survivors of PBTs (Reddick et al., 2014). When 
individuals with infratentorial brain tumors treated with radiation were compared to other 
survivors of PBTs treated with surgery only, researchers found that those treated with 
radiation had deficits in information-processing speed, likely associated with white-
matter damage (De Ruiter et al., 2013; Mabbott et al., 2008). White matter damage has 
been correlated with deficits in executive functioning, as well (Maddrey et al., 2005; 
Ronning, Sundet, Due-Tonnessen, Lundar, & Helseth, 2005; Spiegler et al., 2004; Wolfe, 
Madan-Swain, & Kana., 2012).  Furthermore, white matter damage has been found to 
explain deficits in IQ and attention (Reddick et al., 2003).  
Attention and Executive Functioning   
Attentional skills have been a focus of PBT research. Many studies use the 
Connors Continuous Performance Test (CPT). Reeves et al. (2006) found statistically 
significant deficits for indices and overall composite scores for survivors of 
medulloblastoma. As time progressed since treatment, performance in these domains 
decreased. Commission scores were significantly lower than average, meaning that the 
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sample performed better than the normative sample. In contrast, a high mean number of 
omission errors has been found in meta-analytic research (De Ruiter et al., 2013). Deficits 
in the overall composite score from the CPT is consistent with other research with a 
broader sample of survivors of PBTs (Reddick et al., 2003; Reddick et al., 2014). 
Selective attention was studied in 54 survivors of posterior fossa tumors treated 
with radiation and surgery or surgery only compared to a control group (Mabbott, 
Snyder, Penkman, &Witol, 2009). Results found impaired attentional skills in survivors 
of posterior fossa tumors, regardless of treatment modality, with those receiving 
craniospinal RT showing more significant impairment (Mabbott et al., 2009).  
Executive Functions  
Executive functioning, which includes many cognitive functions, such as working 
memory, attention, cognitive flexibility, and planning and organization, can also be 
affected by treatment for PBTs. Studies have found impaired executive functioning for 
adult survivors of medulloblastoma (Brinkman et al., 2012). Additionally, Beebe et al. 
(2005) found below-mean scores in regard to executive functioning for survivors of 
astrocytoma and medulloblastoma, even though those with astrocytoma were treated with 
surgery only. Furthermore, Maddrey et al. (2005) found deficits in planning and cognitive 
set shifting for a large percentage of survivors of medulloblastoma treated with 
craniospinal RT. Of note, this follow-up was at least 10 years.  
Additionally, Winter et al. (2014) evaluated inhibition and cognitive flexibility for 
those diagnosed with a brain tumor versus acute lymphoblastic leukemia (ALL). Their 
research using the Delis-Kaplan Executive Function System (DKEFS) found that those 
diagnosed with a brain tumor showed significant executive-function deficits, specifically 
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on inhibition and switching tasks. Furthermore, performance in this domain was 
significantly below that which would be found based on estimation of IQ (Winter et al., 
2014). 
Memory  
Reeves et al. (2006) postulated that lower cognitive functioning seen in survivors 
of PBTs could be caused by the slower rate of acquiring the knowledge necessary for 
learning. One should note that attention and memory may underlie this slower rate, and 
therefore, the authors investigated these two areas of cognitive functioning to determine 
if they were correlated with deficits often seen in survivors of PBTs. The authors focused 
only on individuals who had been diagnosed with medulloblastoma. The mean age of the 
sample (n = 38) was 8.34 years old, and most participants were younger than 2 years old 
post RT. Results from the California Verbal Learning Test-Child Version (CVLT-C) 
showed  no significant performance differences when  comparing the sample to the 
normative sample; however, all subtest scores fell below the standardized mean of zero, 
leading to a trend of below-average functioning for the group (Reeves et al., 2006).  
Other research has found the same, with verbal memory remaining intact over time, but 
visual memory declining (Spiegler et al., 2004). This finding is in contrast to other 
studies; Mulhern et al. (2001) found that for survivors of medulloblastoma, performance 
on the CVLT was lower than the age-corrected norms. Reddick et al. (2003) found this 
pattern as well with a group of survivors of posterior fossa tumors. Meta-analytic studies 
have found that for astrocytoma, ependymoma, and medulloblastoma, survivors of all 
three tumor types performed lower than population norm, but survivors of 
medulloblastoma performed significantly worse than survivors of astrocytoma in regard 
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to memory skills (Hanzlik et al., 2015).  Again, this difference was postulated to relate to 
radiation given to each of the three tumors (i.e., focal for ependymoma, craniospinal  for 
medulloblastoma, and none for astrocytoma).  
Academic Achievement  
Difficulties in attention, executive functioning, and memory, among other 
cognitive domains, can have a profound effect on one’s ability to be successful in an 
academic setting. Additionally, individuals with infratentorial PBTs are treated with 
craniospinal RT, are more likely to experience school problems when compared to other 
individuals with PBTs, and are more likely to use special-education services when 
compared to survivors of other cancers (Barrera, Shaw, Speechley, Maunsell, & Pogany., 
2005; Mabbott et al., 2008; Nelson et al., 2013; Northman, Ross, Morris, & Tarquini, 
2014).  Academic achievement problems have been well documented in meta-analytic 
research (Robinson et al., 2012). 
 Studies have attempted to investigate moderating variables for decline in 
academic achievement. Nelson et al. (2013) found that younger survivors of 
medulloblastoma were rated as having poorer academic performance compared to their 
older counterparts. Additionally, Reeves et al. (2006) found that time since radiation was 
associated with math and spelling deficits, meaning that the more time since the start of 
radiation, the worse a survivor’s performance, although the researchers could not find a 
predictive value for radiation dose or age. Reading skills were affected for survivors of 
ependymoma, but skills regarding math and spelling were largely intact in another study 
(Conklin, Li, Xiong, Ogg, & Merchant, 2008). After controlling for time since radiation, 
errors in omission (Connors Continuous Performance Test [CPT]) were significantly 
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associated with deficits in reading and math, but had no effect on spelling for a group of 
survivors of medulloblastoma (Reeves et al., 2006). Math and written-expression scores 
fell significantly below expectations for a group of survivors of PBTs (Bonner, Hardy, 
Willard, & Gururangan, 2009). Even though the consensus is mixed regarding which 
academic skills are affected most from the treatment of PBTs, research has indicated that 
survivors of PBTs are more likely to repeat a grade in school or to have deficits in 
education attainment (Ellenberg et al., 2009; Kahalley et al., 2013). Authors postulate this 
finding to failing to receive the adequate services and accommodations. 
Infratentorial Versus Supratentorial Brain Tumors  
In addition to investigating moderating variables, studies have focused upon the 
comparison of infratentorial and supratentorial tumors and the potential deficits seen. 
Patel et al. (2011) were interested in this aspect and did not find a difference in cognitive 
functioning (i.e., IQ) between the two groups, but those with infratentorial tumors had 
significantly worse measures of academic achievement, attention, and working memory 
and parent reports of behavioral functioning. Additionally, 37.5% of individuals with 
infratentorial tumors qualified for a learning disability while only 13% of individuals 
with supratentorial tumors did (Patel et al., 2011). These findings are in contrast to the 
findings of King et al. (2004). In their study, individuals with tumors in the 
supratentorium were also compared to those with tumors in the infratentorium on varying 
memory tasks, including verbal memory (King et al., 2004). Results showed that while 
participants with supratentorial tumors did worse on list-learning tasks and verbal-
memory skills, those with infratentorial tumors did worse on basic repetition tasks and 
tapping into attention span (Digit Span from Wechsler tests).  These results led to the 
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authors postulating that the two groups had different profiles of cognitive impairment, an 
assumption in line with other studies (Patel et al., 2011). 
Bonner et al. (2009) also investigated survivors of both infratentorial and 
supratentorial brain tumors. Their study included 101 individuals at least 1 year post 
treatment for diagnosed PBTs. Of the PBTs, 56.4% were located in the posterior fossa, 
28.7% were located in the third ventricle, and 14.9% were located in the cerebral 
hemisphere, and74.3% were treated with RT with or without chemotherapy, surgery, or 
both.  Results were consistent with previous research in that cognitive functioning was 
below average with significantly higher verbal IQ scores compared to performance IQ 
scores (Bonner et al., 2009; De Ruiter et al., 2013). Visual motor functioning as assessed 
by the Beery-Buktenica Developmental Test of Visual Motor Integration (Beery VMI) 
demonstrated low average scores (M = 81.5; SD = 15.5), consistent with previous 
research (Spiegler et al., 2004). Below average processing speed, which was evaluated 
using the Wechsler scales (M = 81.3; SD = 17.61), was also seen (Bonner et al., 2009). 
Lastly, participants performed worse on visual-memory tasks (M = 7.8; SD = 2.8) when 
compared to verbal-memory tasks (M = 8.5; SD = 3.30).  Even though the authors 
included a wide range of pediatric-tumor types in this study, the most frequent tumors 
were medulloblastoma (n = 34; 33.7%), pilocytic astrocytoma (n = 12; 11.9%), and 
ependymoma (n = 13; 12.9%). With most tumors located in the posterior fossa, an overall 
finding showed weakness in visual motor functioning, stronger verbal-memory skills, and 
stronger verbal skills overall when compared to nonverbal skills (Bonner et al., 2009).  A 
significant decline in visual motor functioning has also been found in survivors of 
infratentorial tumors in other studies (Spiegler et al., 2004) 
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Overall, evidence shows that individuals treated with surgery, radiation, and/or 
chemotherapy have poor neurocognitive outcomes, including deficits in areas of memory, 
executive-functioning, visual-processing, and visual-motor skills. Adding RT to the 
treatment protocol leads a greater global loss of IQ points (De Ruiter et al., 2013; Fossati 
et al., 2009; Mabbott et al., 2008; Nelson et al., 2013; Palmer et al., 2003). Conventional 
RT delivered to the posterior fossa usually includes the cerebellum and scatters to 
portions of the temporal lobes, leading to deficits in attention, language skills, memory, 
visual motor functioning, and academic functioning (Bonner et al., 2009; De Ruiter et al., 
2013; Reddick et al., 2003; Reeves et al., 2006; Spiegler et al., 2004; Winter et al., 2014). 
Proton Radiation Therapy 
With the advancement of PRT comes the sparing of tissue surrounding the tumor 
(Antonini et al., 2017; Khuntia et al., 2009; Rombi, Vennarini, Vinante, Ravanelli, & 
Amichetti, 2014). Protons are charged particles with mass and deposit energy until 
reaching the maximum penetration depth (i.e., Bragg peak). The maximum penetration 
depth can be manipulated to place the Bragg peak at a specific depth in the body. Once 
this depth is reached, the energy is lost rapidly over a short distance, thus reducing the 
exit dose (Cotter et al., 2012; Khuntia et al., 2009). For example, if the depth dose is 8 
mm, the dose fall-off beyond that depth is rapid.  Thus, the PRT dose falls to zero within 
a few millimeters beyond its maximum depth (Khuntia et al., 2009). Because of the 
precise accuracy of PRT, it can be used on younger patients (Semenova, 2009). 
PRT has three major kinds of delivery. The first, passively scattered, is used most 
commonly. With this type of delivery, the proton beam is laterally spread out over the 
area that needs treatment. The second, pencil beam scanning, involves the proton beam 
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scanning over the depth and shape of the target, completely covering the target.  Fewer 
neutrons are scattered in this modality, thus leading to decreased risk of second 
malignancies. The third, IMRT, is used when a critical structure is near the target 
(Hoffman & Yock, 2009).  
Even though PRT is more precise and potentially less damaging when compared 
to traditional RT, adverse effects do exist (Semenova, 2009). A small amount of healthy 
tissue may still receive an integral dose of radiation, even when using the most precise 
distribution (Semenova, 2009). Long-term effects of PRT are theorized to be fewer 
compared to those of conventional RT, but overall cognition still can be affected by PRT 
(Semenova, 2009).  Semenova (2009) discussed the possibility of neutron contamination. 
Unlike protons, neutrons deposit radiation doses over the entire path and do not stop at 
the tumor site. If contamination during production occurs, areas of the brain may be 
exposed to significant amounts of radiation. Unfortunately, the contamination is most 
likely to be unknown to the provider (Semenova, 2009).  However, Fossati et al. (2009) 
stated that dose of neutrons is 100 times smaller than that of protons, so that magnitude of 
insult remains unclear.  Nonetheless, PRT has been associated with sparing of 
functioning, such as IQ (Gondi et al., 2016; Ventura et al., 2018).  
Jimenez et al. (2013) investigated the use of PRT and evaluated children 
diagnosed with either medulloblastoma (n = 12) or supratentorial primitive 
neuroectodermal tumor (PNET; n = 3). Mean age of participants was 35 months and 
ranged from 23 to 55 months. Many areas, including audiological functioning, overall 
survival,  cognitive functioning, and adaptive functioning, were evaluated for this cohort 
(Jimenez et al., 2013). Of the surviving participants, five were given follow-up cognitive 
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testing. Results showed no significant differences between the baseline and follow-up 
testing for cognitive functioning. Median follow-up occurred at 26 months, but ranged 
from 15 months to 38 months (Jimenez et al., 2013).  Even though there was a small 
sample size and an even smaller follow-up, the study showed that PRT may be effective 
for patients younger than 3 years old.  This finding is promising given that previous 
research has stated that children younger than the age of 3 years should not receive RT 
(De Ruiter et al., 2013).  
Pulsifer et al. (2015) looked at various measures from the Wechsler scales of 
intelligence for 60 patients treated with PRT. Those treated for medulloblastoma received 
whole-brain PRT, and those with craniopharyngioma, low-grade glioma, and 
ependymoma received radiation at the tumor site alone. The authors looked at baseline 
and follow-up data, with the mean follow-up of 2.5 years. At baseline, all scores were in 
the Average range, although processing speed was below population mean. At follow-up, 
FSIQ scores improved for 55% and declined for 40% of the sample. The decline was seen 
for individuals treated with craniospinal PRT, for those diagnosed with medulloblastoma 
(also treated with craniospinal PRT), and for those treated with focal PRT. However, this 
decline was not statistically significant. Overall, no significant change was found from 
baseline to follow-up for FSIQ scores, but the mean Processing Speed Index (PSI) score 
declined significantly by an average of 5.2 points. Of note, the raw scores for subtests of 
PSI actually increased, indicating that the decline in overall PSI score was possibly the 
result of a reduced rate of skill acquisition of same-aged peers, rather than of a loss of 
skill (Pulsifer et al., 2015).  
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 A decline in processing speed has also been found in other studies. For example, 
Ventura et al. (2018) found Low Average processing speed at follow-up. Although their 
sample included all brain tumors, the majority (55%) of their sample of 65 patients had 
infratentorial tumors. Of note, about 44% of the sample was diagnosed with 
medulloblastoma. The study concluded that individuals who underwent PRT 
demonstrated overall Average intellectual abilities and academic skills approximately 3 
years after treatment. The authors hypothesized, as others have, that the weaknesses in 
processing speed were related to the adverse effects of PRT on white-matter networks. 
Furthermore, lower processing speed and working memory were significantly related to 
those participants who received craniospinal PRT compared to focal PRT. Thus, this 
discrepancy further suggests the effects on white matter from PRT (Ventura et al., 2018). 
 Antonini et al. (2017) also investigated the effect of PRT on processing speed, in 
addition to attention and executive functions. They looked at the sample as a whole and 
also included certain demographic information for comparisons. Their sample included 
39 participants with 57% being diagnosed with an infratentorial brain tumor. Average 
follow-up was at 3 years post treatment. Discrepancies in scores were seen between the 
craniospinal and focal groups. Overall, attention scores did not differ from the normative 
mean on any CPT-II scale and were not affected by any demographic variable for the 
craniospinal group. Additionally, the craniospinal group differed from the normative 
mean in regard to inhibition abilities, motor coordination, and visual perception. 
Attention, processing speed, and aspects of executive function did not differ from 
normative means for the focal group. Therefore, Antonini et al. (2017) concluded that 
craniospinal PRT is a risk factor. One should note, though, that although the group 
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performed worse than the normative sample, the means for the group fell solidly within 
the Average range across all tasks, with the exception of scores on the Trail Making Test. 
Additionally, those diagnosed with an infratentorial tumor and had a history of shunt 
placement exhibited worse performance on processing-speed and executive-function 
abilities. The infratentorial group was significantly younger at treatment and more likely 
to receive craniospinal PRT compared to the supratentorial group, although the 
synergistic effect of age and craniospinal PRT is largely unknown (Antonini et al., 2017).  
 Although most studies focus upon IQ, processing speed, and executive 
functioning, Zureick et al. (2018) focused their research upon verbal- and visual-memory 
functioning for a total of 70 patients treated with PRT. The median follow-up for this 
group was 3 years, and the majority (51%) of individuals had been diagnosed with 
infratentorial brain tumors. Overall, the cohort performed within normal range for both 
verbal and visual memory. A story memory task was used to assess verbal memory and 
Dot Locations from the Children’s Memory Scale (CMS) or Family Pictures from the 
Wechsler Memory Scale – Third Edition (WMS-III) was used to assess visual-memory 
abilities.  
 Overall, research regarding the impact of PRT for PBTs is sparse (Antonini et al., 
2017). Most studies focus upon one or two neurocognitive domains and often have very 
small heterogeneous sample sizes. Nonetheless, early studies thus far have shown that 
PRT appears to spare healthy tissue and potentially to have less of an impact on 
neurocognitive domains than does conventional RT.  
 
 
 NEUROPSYCHOLOGICAL FUNCTIONING FOR PBT SURVIVORS                    39 
 
In comparing those treated with PRT versus more conventional (i.e., photon) RT, 
some studies have been successful in showing the superiority of PRT over conventional 
RT. For example, clinical trials using PRT for ependymoma found that those treated with 
PRT compared to IMRT had significantly less radiation to such areas as the cochlea, 
temporal lobes, and hypothalamus while keeping radiation dose to the tumor equal to 
other radiation modalities using historical samples (MacDonald et al., 2013).  
Additionally, for those treated for medulloblastoma using PRT, their cochlea, 
hypothalamus, pituitary, and temporomandibular joint were spared using planning 
models (Hoffman & Yock, 2009; Khuntia et al., 2009; Rombi et al., 2014; St. Clair et al., 
2004). Additionally, the incidence of radiation-induced secondary tumors is reduced 
using PRT, even though longer follow-up studies are needed (Fossati et al., 2009; Rombi 
et al., 2014).  Furthermore, cognitive functioning and adaptive skills were found stable 
for individuals treated with focal PRT for ependymoma; children under the age of 3 years 
demonstrated lower cognitive functioning at baseline in comparison to others, but their 
functioning improved substantially over time  (MacDonald et al., 2013). This 
improvement was hypothesized to result from the sparing of temporal lobes and cerebrum 
from high doses of radiation.  
Merchant et al. (2008) also compared proton and photon RT for common PBTs 
and their effects on cognitive function. The missing exit dose and steep distal-dose 
gradients with protons are superior to photon RT, even the most advanced kinds 
(Merchant et al., 2008).  This study chose individuals with tumors that were similar in 
location, size, and volume and included optic-pathway glioma, craniopharyngioma, 
ependymoma, and medulloblastoma. The optic-pathway glioma and craniopharyngioma 
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were in the supratentorium, while the ependymoma and medulloblastoma tumors were in 
the infratentorium. The overall finding suggests that protons lower the distribution of 
radiation doses to other portions of the cerebrum. For those individuals treated for 
ependymoma, protons showed an advantage compared to photon radiation by reducing 
the potential for endocrine effects and hearing loss (Merchant et al., 2008).  This potential 
for reduction was also the case for individuals treated for medulloblastoma, except the 
potential for endocrine effects was similar to that of photons. Overall, the study helped 
show the advantages of protons in reducing doses of radiation to normal tissues 
(Merchant et al., 2008).    
Kahalley et al. (2016) also investigated the differences between PRT and photon 
RT. The majority (54.2%) of individuals were treated for an infratentorial brain tumor. 
Overall, they found that when adjusting for time since RT, lower IQ scores were 
associated with photon RT, younger age, infratentorial location, and history of shunt. 
Furthermore, IQ scores were significantly lower in the photon RT group compared to the 
PRT group by 8.7 points on average (Kahalley et al., 2016). As a caveat, no significant 
difference in change in IQ over time was found between the two groups (i.e., PRT vs. 
photon RT), so whether PRT is clinically meaningful in sparing IQ points is difficult to 
ascertain (Kahalley et al., 2016). Limitations of this study included low power, less 
follow-up in the PRT group, use of global IQ scores as comparison, and the measurement 
of IQ using three different measures. Furthermore, Yock et al. (2016) found that the mean 
loss of IQ was lower over time for those treated with protons compared to those treated 
with photons, even though the proton group included younger patients and a diverse 
group of low- and high-risk tumors.  
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Survivorship 
Although brain tumors account for 20% of all pediatric malignancies, 
advancements in chemotherapy, surgery, and radiation have dramatically improved the 5-
year survival rates for children with a brain tumor. Survival rate for individuals diagnosed 
with a primary malignant brain tumor and other CNS tumors (e.g., lymphoma, leukemia) 
is 73.9% for those aged 0 to 19 years. Survival after a diagnosis of a nonmalignant brain 
or other CNS tumor is 90.47% (Surveillance Epidemiology and Ends Results [SEER] 
Program, 2016).  However, numerous adverse consequences are caused by treatment for 
PBTs. These treatments can have an impact on neurologic function and quality of life for 
these survivors (Ullrich & Pomeroy, 2003), as well as long-term cognitive and 
psychological sequalae (Meyer & Kieran, 2002).  
Neurocognitive deficits are common, affecting 40 to 100% of survivors, 
depending on age at diagnosis and treatment modalities (Nelson et al., 2013). Compared 
to survivors of other malignancies, survivors of PBTs are at the greatest risk for 
neurocognitive deficits (De Ruiter et al., 2013). For example, survivors treated for 
medulloblastoma often have late effects, including neurocognitive, hormonal, and hearing 
deficits, and have an increased risk for secondary tumors. Additionally, poorer quality of 
life is reported, as well as a decreased likelihood of getting married, having a job, or 
living independently (Yock et al., 2016).  
Age 
 Overall, research regarding the effect of age at diagnosis of survivors of PBTs 
varies, with research particularly investigating age and PRT especially sparse. Some 
studies report young age as protective, while other studies report worse outcomes for 
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younger patients (De Ruiter et al., 2013; Levisohn et al., 2000; Wolfe et al., 2012). Others 
state that the correlation between age at diagnosis and neurocognitive deficits is still 
unclear (De Ruiter et al., 2013).  Levisohn et al. (2000) found that the youngest patients 
at the time of neuropsychological evaluation were the least likely to show deficits after 
surgery for tumor resection; 33% of those younger than 7 years old showed deficits, 
compared to 80% of those older than 7 years old who showed deficits. Additionally, these 
age effects were confounded by tumor type; 75% of those younger than 7 years old had 
astrocytoma or ependymoma compared to medulloblastoma for those older than 7 years. 
Of note, this pattern is opposite to the pattern seen for the long-term outcomes for those 
treated with cranial radiation (Levisohn et al., 2000).  This finding is similar to the 
finding of Patel et al. (2011); in their research, a significant positive correlation was 
found between age at diagnosis and FSIQ, academic achievement, and working memory 
for individuals with both infratentorial and supratentorial tumors (Patel et al., 2011). 
Schmahmann and Sherman (1998) found similar results in that those younger at the time 
of diagnosis were associated with better cognitive and behavioral outcomes. The authors 
posited that these results might be due to lack of testing sensitivity, neural plasticity, or 
different tumor types. However, one should note that most studies reporting 
protectiveness of young age are found in older literature.   
In contrast, a meta-analysis conducted by Hanzlik et al. (2015) looked at survivors 
of medulloblastoma and ependymomas and found age at diagnosis to be a significant 
predictor of poor neuropsychological functioning. Moreover, a correlation was found 
between younger age and poor IQ scores, executive functioning, and memory (Hanzlik et 
al., 2015). However, when looking at the studies evaluating astrocytomas, only one of six 
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found a correlation between younger age at diagnosis and poor cognitive performance, 
while the rest of the studies found no correlation.  
Pulsifer et al. (2015) investigated the effect of age on FSIQ scores over time. The 
mean age of their group was 12 years, so the two groups were divided at the mean. At 
baseline, the younger group scored significantly higher for FSIQ, PRI, and PSI scores, 
while significant changes were seen for both groups in PSI scores at follow-up. Overall, 
no significant changes were seen within age groups for FSIQ, and the difference between 
groups fell short of statistical significance (Pulsifer et al., 2015).  
 Even though two sided, the research has found that the young brain is vulnerable 
to the treatment of PBTs because of dendritic and axonal outgrowth, myelination, and 
rapid cell proliferation that takes place starting in infancy and going throughout 
adolescence (De Ruiter et al., 2013).  Additionally, those younger than 36 months 
experience the most severe cognitive delays (Semenova, 2009). These issues led to the 
postponement by medical professionals of any radiation for children under the age of 3 
years (De Ruiter et al., 2013).  Additionally, Mulhern et al. (2001) found that younger age 
at treatment using RT was most likely a moderating variable between radiation dose and 
cognitive outcomes; higher doses led to worse cognitive outcomes. This finding led to 
other studies investigating the effectiveness of RT at lower doses (Mulhern et al., 2001). 
However, neurocognitive deficits following RT may not appear until many years after 
treatment. Therefore, longitudinal studies are needed to fully understand the effect of RT 
on a survivor of PBT (Wolfe et al., 2012).  
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Treating Neuropsychological Deficits in Survivors of PBTs 
 Regardless of treatment modality used for PBTs, a well-established body of 
literature demonstrates how deleterious the treatments can be for survivors of PBTs. 
Survivors of PBTs have difficulty in a school environment for a variety of reasons, 
especially neurocognitive deficits from treatment. Processing speed impacts an 
individual’s ability to access the learning environment because of it’s impact on the 
ability to understand, retain, and recall new ideas and concepts (Satariano, 2016). 
Unfortunately, children with processing-speed deficits may be regarded as lazy or 
defiant. They are often last to complete work or to turn in a test at school. Some may not 
complete the schoolwork or homework assigned (Winter et al., 2014). Fortunately, this 
deficit can be resolved with simple accommodations, such as extra time on exams 
(Kahalley et al., 2013). Difficulties in attention also affect a survivor because of issues in 
encoding, understanding, and recalling information later. Satariano (2016) found that the 
larger the classes, the more demanding the work becomes and the greater the impact on 
attentional difficulties for the survivors of PBTs. When these difficulties are combined 
with executive-functioning difficulties, the ability to navigate a classroom can become 
extremely difficult. Furthermore, issues in working memory can exacerbate these issues 
and cause difficulties in processing and using instructions, following multistep 
instructions, and performing multiple cognitive tasks at once. Thus, monitoring of 
students and communication among teaching staff are needed to ensure survivors are 
taken care of properly. Communication between school and parents helps increase the 
understanding of a child’s needs, and teaching staff should be supported to increase their 
 NEUROPSYCHOLOGICAL FUNCTIONING FOR PBT SURVIVORS                    45 
 
awareness and understanding of the complex treatment history and its effects on the 
survivor’s ability to function within the academic environment (Satariano, 2016).  
 Cognitive-rehabilitation programs can also be helpful for survivors of PBTs. 
Such programs began in the late 1980s and were used primarily with adults with a history 
of a traumatic brain injury (Butler et al., 2008; Olson & Sands, 2016). These programs 
were then applied to the field of pediatric oncology in the 1990s. The effectiveness and 
feasibility of these cognitive-remediation programs have been and still are topics of 
research. A meta-analysis conducted by Olson and Sands (2016) found that the majority 
of articles addressed a single skill (e.g., attention), while others focused on two to five 
skills. Academic and attentional abilities were the focus of most research. An 
improvement in attention was reported in about 80% of studies. Mixed results were found 
for working memory and math skills, although the results appeared promising. Improving 
reading and executive functioning was reported to be more challenging. Individuals with 
higher preintervention IQ scores demonstrated greater improvement overall. Of note, the 
majority of the interventions used in these studies were primarily clinic based or home 
based. Clinic-based programs used both one-on-one therapy and computer-based 
programs. All home-based programs were computer based. The average completion rate 
for home-based programs was 81%, and the average completion rate for clinic-based 
programs was 73%. Therefore, the home-based programs appeared more feasible than the 
clinic-based programs, which required weekly clinic visits and associated expenses and 
time. Overall, the best outcomes were a result of home-based treatment, after treatment, 
and some involvement of a parent or caregiver. 
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Wolfe et al. (2012) also discussed a few studies that investigated the efficacy of 
cognitive-intervention programs. For all interventions, improvements were made in 
learning strategies, academic domains, social skills, writing skills, and working-memory 
abilities (Wolfe et al., 2012). As a caveat, these studies included small sample sizes and 
lacked control groups. Therefore, more research is needed in this area to evaluate the true 
potential of cognitive-intervention models and/or programs.  
Unfortunately, responsibility for longer term cognitive-rehabilitation programs 
has shifted to the school, but schools lack necessary resources, such as funds and trained 
professionals. Therefore, research suggests that outpatient cognitive rehabilitation be put 
back into the hands of psychiatry, neuropsychology, and neurology (Butler et al., 2008).  
Also, a team approach, including health professionals, school professionals, and the 
family, is recommended. Overall, the patient’s characteristics, physiology, 
neurocognitive impairment, psychosocial environment, and family-related functioning 
should be evaluated when creating a plan for cognitive rehabilitation (Butler et al., 2008). 
Purpose of the Study 
The literature is limited regarding specific cognitive and adaptive profiles 
associated with tumor location for long-term survivors of infratentorial PBTs (Patel et al., 
2011).  Owing to the higher incidence of infratentorial tumors affecting children and 
adolescents, knowing the long-term neuropsychological effects, such as intelligence, 
memory, attention, processing speed, and visual-spatial integration, is paramount.  
Because PRT is a relatively new advancement used for PBTs, the research is limited. 
Additionally, research regarding the effect of age is mixed (De Ruiter et al., 2013; 
Levisohn et al., 2000; Wolfe et al., 2012). Therefore, the aim of this study is to 
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investigate the effects of age at diagnosis on cognitive abilities, memory, attention, 
processing speed, and visual-spatial/visual-motor integration for those survivors of 
infratentorial PBTs treated with PRT. This knowledge will not only help determine 
whether age at diagnosis affects neuropsychological functioning, but also will guide 
interventions and rehabilitation strategies for survivors of PBTs.  
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Chapter 3: Research Question and Hypotheses  
Overall Question 
The current study is guided by the following questions: What is the magnitude of 
deficits seen after PRT treatment for survivors of PBTs? Does age at diagnosis have an 
effect on the neurocognitive functioning of individuals with infratentorial PBTs? These 
questions were examined by analyzing neuropsychological follow-up data for children 
and adolescents treated with PRT for infratentorial brain tumors.  
Hypothesis 1 
In comparing age at time of diagnosis, it is hypothesized that younger individuals will 
demonstrate significantly poorer verbal and visual cognitive abilities as measured by VCI 
and PRI respectively in comparison to older individuals at time of follow-up while 
accounting for time since diagnosis.  
Rationale: Although the research is mixed, previous research has shown that the younger 
a child is when receiving treatment for PBTs, the more neurocognitive deficits and the 
more severe these deficits (Nelson et al., 2013; Semenova, 2009). Risk factors for 
intellectual decline have included younger age at start of treatment, increased time since 
diagnosis, and higher RT dose (Palmer et al., 2003).  
Hypothesis 2 
In comparing age at time of diagnosis, it is hypothesized that younger individuals will 
demonstrate significantly weaker memory abilities as measured by Dot Location Long 
Delay, Faces Long Delay, Story Memory Long Delay, and CVLT Free Recall Long 
Delay in comparison to older individuals at time of follow-up while accounting for time 
since diagnosis. 
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Rationale: A correlation between younger age and poor IQ scores, executive functioning, 
and memory has been found (Hanzlik, 2015).  
Hypothesis 3 
In comparing age at time of diagnosis, it is hypothesized that younger individuals will 
demonstrate significantly less developed visual-motor skills as measured by the Beery 
VMI and Purdue Pegboard - Dominant Hand in comparison to older individuals at time 
of follow-up while accounting for time since diagnosis. 
Rationale: The location and treatment of infratentorial tumors is usually associated with 
problems with coordination, visual problems, visual-spatial functioning, and other motor 
problems (Korah et al., 2010; Levisohn et al., 2000).  
Hypothesis 4 
In comparing age at time of diagnosis, it is hypothesized that younger individuals will 
demonstrate significantly slower processing speed as measured by the PSI in comparison 
to older individuals at time of follow-up while accounting for time since diagnosis.   
Rationale: Research has shown below-average processing speed for those with 
infratentorial brain tumors (Bonner et al., 2009; Kahalley et al., 2013; King et al., 2004). 
Hypothesis 5 
In comparing age at time of diagnosis, it is hypothesized that younger individuals will 
demonstrate significantly poorer attention and inhibition abilities as measured by CPT –
II/3 Commissions, TEA-Ch Walk/Don’t Walk, CPT-II/3 Omissions, and TEA-Ch Score! 
in comparison to older individuals at time of follow-up while accounting for time since 
diagnosis.  
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Rationale: Overall, attention deficits are frequently reported impairments for individuals 
affected by PBTs (De Ruiter et al., 2013; Nelson et al., 2013). Deficits in attention, 
memory, and executive functioning are typically seen within 1 to 2 years post treatment 
with surgery, chemotherapy, and/or photon RT (Patel et al., 2011).   
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Chapter 4: Methods 
Design 
 The current study used an archival-data design. The study used a quantitative 
design to measure functioning at follow-up. This design was selected in order to identify 
the effect age at diagnosis has on neurocognitive functioning for children and adolescents 
treated with proton radiation therapy (PRT) for their infratentorial tumors.  
Inclusion and Exclusion Criteria 
 Participants were eligible to participate in the Proton Radiation Therapy Data 
Registry for Childhood Tumors if they were patients who had received PRT and 
participated in a neuropsychological evaluation. Inclusion criteria for the present study 
included a diagnosis of an infratentorial tumor, receipt of PRT at the Children’s Hospital 
of Philadelphia (CHOP), and a completed neuropsychological assessment at least 2 years 
post radiation between January 1, 2010, and September 20, 2017.   
Participants were excluded from the Proton Registry if they were not CHOP 
patients and/or if they did not receive PRT. Exclusion criteria for the current study 
included a diagnosis of a supratentorial tumor, received PRT at an institution other than 
CHOP, and/or lack of follow-up data at least 2 years post radiation.  
Recruitment 
 Potential participants were identified by exploring the electronic health record 
(EHR), EPIC, to determine if they had received a neuropsychological evaluation through 
the Division of Oncology at CHOP.  
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Participants 
 A total of 25 participants met inclusion criteria for the current study. However, 
one participant was ultimately excluded from the dataset because of a very complex 
medical history resulting in significantly impaired functional abilities such that the 
participant completed only one measure pertinent to the overall data set (score on Beery 
VMI). Therefore, 24 participants were included in the current study.  Table 1 shows an 
overview of the participant characteristics of the study sample. 
  
Table 1 
 
 Participant Characteristics  
Variable n (%)   
Gender 
 Male     19 (79.2) 
 Female        5 (20.8) 
Age (years) 
 8 and older        9 (37.5) 
 7 and younger    15 (62.5) 
Chemotherapy Hx  
 Yes      16 (66.7) 
 No        8 (33.3) 
Tumor type 
 Medulloblastoma       7 (29.2) 
 Ependymoma      5 (20.8) 
 Anaplastic ependymoma      5 (20.8) 
 Astrocytoma       2 (8.3) 
 Glioma        1 (4.2) 
 NGGCT       1 (4.2) 
 Cerebellar ganglioma     1 (4.2) 
 ATRT       1 (4.2) 
 Tectal germinoma       1 (4.2) 
PRT volume 
 Focal     18 (75) 
 Craniospinal       6 (25) 
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PRT dose –Focal (cGy) 
 3000       1 (5.6) 
 5400       9 (50) 
 5760       1 (5.6) 
     5940       7 (38.9) 
PRT dose – CSI (cGy) 
 2340       4 (66.7) 
 3600       2 (33.3) 
CSI dose + boost (cGy) 
 2340 + boost to 5400     3(50.0) 
 2340 + boost to 5580     1 (16.7) 
 3600 + boost to 5400     2 (33.3) 
Recurrence after PRT 
 Yes        3 (12.5) 
 No      21 (87.5) 
Pre-existing medical and/or behavioral health conditions 
 Yes        4 (16.7) 
 No       20 (83.3) 
Posttreatment medical consequences  
 Yes        9 (37.5) 
 No       15 (62.5) 
Mental-health diagnosis post treatment  
 Yes      10 (41.7) 
 No       14(58.3) 
___________________________________________________________   
      M  SD  Range_ 
Age at initial diagnosis   7.8  5.45  1-19 
Age at initial diagnosis for males 7.5  5.47  1-19 
Age at initial diagnosis for females 9.0  5.83  3-17 
Age at most recent sssessment         12.1  5.85  4-28 
Years since initial diagnosis  4.3  2.40  2-11 
Follow-up years since PRT  3.7  1.71  2-10 
Years since retreatment (n = 1) 2  ---  ---_____ 
Note. Hx = history; NGGCT = non-germinomatous germ cell tumor; ATRT = atypical 
teratoid rhabdoid tumor; PRT = proton radiation therapy  
 
 A total of three participants had experienced tumor recurrence prior to the most 
recent neuropsychological evaluation. One participant was originally diagnosed with 
anaplastic ependymoma and treated with focal PRT (5940 cGy) and then had an 
exoprimary recurrence in the left frontal horn of the lateral ventricle and was treated with 
craniospinal PRT (3600 cGy to the craniospinal axis with a boost to the tumor bed of 
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2340 cGy for a cumulative dose of 5940 cGy). A second participant was also diagnosed 
with an anaplastic ependymoma that was treated with focal PRT (5760 cGy); tumor 
regrowth was then treated with surgery and chemotherapy only. The third participant was 
diagnosed with a posterior fossa ependymoma, which was originally treated with focal 
PRT (5940 cGy) with recurrence in the spinal column. This person was subsequently 
treated with spinal radiation.  
 A number of pre-existing conditions existed for this cohort of participants, 
including prematurity (n = 1), mild hypoxia at birth and autism spectrum disorder (n = 1), 
autism spectrum disorder (n = 1), and prematurity and attention deficit/hyperactivity 
disorder (ADHD; n = 1). A number of medical consequences were also noted for this 
participant group and included sensorineural hearing loss (n = 5), vision problems (e.g., 
diplopia; n = 3), left-sided hemiplegia (n = 1), balance and speech problems (n = 1), and 
hydrocephalus (n = 2). Furthermore, a number of participants were diagnosed with a 
mental-health condition post treatment. These conditions included mixed expressive-
receptive language disorder (n = 1), ADHD (n = 3), depression/anxiety (n = 2), 
dysthymia (n = 1), posttraumatic stress disorder (PTSD; n = 1), specific learning 
disorders (n = 1), and intellectual disability (n = 1).  Furthermore, two patients were 
treated with both intensity-modulated radiation therapy (IMRT) and PRT, with the 
majority of radiation dosage being from protons for both of these participants.   
Measures 
Wechsler Scales (WASI-II, WPPSI-IV, WISC-IV/V, WAIS-IV)  
For cognitive data, Wechsler scales were used to determine Verbal 
Comprehension Index (VCI), Perceptual Reasoning Index (PRI), and Processing Speed 
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Index (PSI) for the current study, as applicable by age. The Wechsler measures have been 
identified as psychometrically valid and reliable instruments and are used most often to 
measure general intelligence in studies with individuals with PBTs (De Ruiter et al., 
2013; Mabbott, et al., 2008).  
The Wechsler Abbreviated Scale of Intelligence – Second Edition (WASI-II) is a 
brief, reliable measure of cognitive ability for use in clinical and research settings 
(Wechsler, 2011). The estimated Full Scale IQ (FSIQ) is composed of the VCI 
(Vocabulary, Similarities) and PRI (Block Design, Matrix Reasoning). Age range for this 
test is 6 to 90 years. Index scores have a mean of 100 and a standard deviation  of 15. 
Subtest scores are presented as  t scores, which have a mean of 50 and a standard 
deviation of 10.  
For the Vocabulary subtest, participants are presented with a word visually and 
verbally and are asked to define the word. For the Similarities subtest, participants are 
verbally presented with two words that represent common objects or concepts and asked 
how they are alike. For the Block Design subtest, the participants are presented with a 
model and/or picture and use colored blocks to recreate the design, within specific time 
limits. Lastly, for the Matrix Reasoning subtest, the participant views an incomplete 
matrix or series and is asked to select a response from possible response options that 
completes the series or matrix.  
The Wechsler Preschool and Primary Scale of Intelligence – Fourth Edition 
(WPPSI-IV) is a measure of cognitive functioning for children aged 2 years,6 months to 
7 years, 7 months (Wechsler, 2012). Index scores for the WPPSI-IV have a mean of 100 
and a standard deviation of 15. Subtest scaled scores have a mean of 10 and a standard 
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deviation of 3. For those aged 2 years, 6 months through 3 years, 11 months, five core 
subtests comprising the FSIQ:  Receptive Vocabulary, Information, Block Design, Object 
Assembly, and Picture Memory. The three Primary Index Scales include VCI (Receptive 
Vocabulary, Information), Visual Spatial Index (VSI; Block Design, Object Assembly), 
and Working Memory Index (WMI; Picture Memory, Zoo Locations).  The subtests that 
comprise the VCI were used in the study. The Receptive Vocabulary subtest asks the 
participant to select the picture that best represents the word that is read aloud by the 
examiner. The Information subtest includes both picture and verbal items. For the picture 
items, the participant is to select the picture that best answers questions about a general-
knowledge topic. For the verbal items, the participant verbally answers questions about a 
broad range of general-knowledge topics.  
For those aged 4 years through 7 years, 7 months, there are six core subtests. The 
FSIQ is composed of Information, Similarities, Block Design, Matrix Reasoning, Picture 
Memory, and Bug Search. The five Primary Index Scales include VCI (Information, 
Similarities), VSI (Block Design, Object Assembly), Fluid Reasoning Index (FRI; Matrix 
Reasoning, Picture Concepts), WMI (Picture Memory, Zoo Locations), and PSI (Bug 
Search, Cancellation). The subtests that comprise the VCI and PSI were used in this 
study. The Information subtest includes both picture and verbal items. For the picture 
items, the participant is to select the picture that best answers questions about a general-
knowledge topic. For the verbal items, the participant verbally answers questions about a 
broad range of general-knowledge topics. For Similarities, the participant is presented 
with two words that represent common objects or concepts and describes how they are 
similar. For Bug Search, the participant marks the bug in the search group that matches 
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the target bug within a specified time limit (120 seconds).  For Cancellation, the 
participant scans two arrangements of objects (one random, one structured) and marks 
target objects within a specified time limit (45 seconds each).  
The Wechsler Intelligence Scale for Children- Fourth Edition (WISC-IV) is a 
measure of cognitive functioning for children aged 6 through 16 years of age (Wechsler, 
2003). The test is composed of 10 core subtests, which are combined to form four index 
scores.  The FSIQ is composed of the VCI (Similarities, Vocabulary, Comprehension), 
PRI (Block Design, Picture Concepts, Matrix Reasoning), WMI (Digit Span, Letter-
Number Sequencing), and PSI (Coding and Symbol Search). Index scores have a mean of 
100 and a standard deviation of 15. Subtest scaled scores have a mean of 10 and a 
standard deviation of 3. Subtests comprising the VCI, PRI, and PSI were used in the 
current study. 
For Similarities, the participant is presented with two words that represent 
common objects or concepts and describes how they are similar. For Vocabulary, the 
participant defines words that are presented both visually and orally. For Comprehension, 
the participant answers questions based on his or her understanding of general principles 
and social situations. For Block Design, the participant uses blocks to recreate a design 
seen visually and/or as a model, within specific time limits. For Picture Concepts, the 
participant is presented with two or three rows of pictures and is asked to choose one 
picture from each row to form a group with a common characteristic. For Matrix 
Reasoning, the participant is asked to look at an incomplete matrix and select the missing 
portion from five response options. For Coding, the participant is asked to copy symbols 
that are paired with simple geometric shapes or numbers. Within a specified time limit 
 NEUROPSYCHOLOGICAL FUNCTIONING FOR PBT SURVIVORS                    58 
 
(120 seconds), the participant draws each symbol in its corresponding box using a key. 
For Symbol Search the participant scans a search group and indicates whether the target 
symbol(s) matches any of the symbols in the search group within a time limit (120 
seconds).  
The Wechsler Intelligence Scale for Children – Fifth Edition (WISC-V) is 
composed of 10 core subtests, which are combined to form five index scores (Wechsler, 
2014). The Primary Index Scales are composed of the VCI (Similarities, Vocabulary), 
VSI (Block Design, Visual Puzzles), FRI (Matrix Reasoning, Figure Weights), WMI 
(Digit Span, Picture Span), and PSI (Coding, Symbol Search). The FSIQ is composed of 
Similarities, Vocabulary, Block Design, Matrix Reasoning, Figure Weights, Digit Span, 
and Coding subtests. Index scores have a mean of 100 and a standard deviation of 15. 
Subtest scaled scores have a mean of 10 and a standard deviation of 3. The subtests that 
comprise the VCI and PSI were used in this study. 
For Similarities, the participant is presented with two words that represent 
common objects or concepts and describes how they are similar. For Vocabulary, the 
participant defines words that are presented orally. For Coding, the participant is asked to 
copy symbols that are paired with simple geometric shapes or numbers. Within a 
specified time limit (120 seconds), the participant draws each symbol in its corresponding 
box using a key. For Symbol Search, the participant scans a search group and indicates 
whether one of the symbols in the target group matches within a time limit of 120 
seconds. 
The Wechsler Adult Intelligence Scale – Fourth Edition (WAIS-IV) is a measure 
of cognitive functioning for those 16 years through 90 years, 11 months of age 
 NEUROPSYCHOLOGICAL FUNCTIONING FOR PBT SURVIVORS                    59 
 
(Wechsler, 2008). The test is composed of 10 core subtests, which combine to form four 
index scores. The FSIQ is composed of the VCI (Similarities, Vocabulary, Information), 
PRI (Block Design, Matrix Reasoning, Visual Puzzles), WMI (Digit Span, Arithmetic), 
and PSI (Coding, Symbol Search). Index scores have a mean of 100 and a standard 
deviation of 15. Subtest scaled scores have a mean of 10 and a standard deviation of 3. 
The subtests that compose the VCI, PRI, and PSI were used in this study.  
For Similarities, the participant is presented with two words that represent 
common objects or concepts and describes how they are similar. For Vocabulary, the 
participant defines words that are presented both visually and orally. For Information, the 
participant answers questions that address a broad range of general-knowledge topics. For 
Block Design, the participant uses blocks to recreate a design seen visually and/or as a 
model, within specific time limits. For Matrix Reasoning, the participant is asked to look 
at an incomplete matrix and select the missing portion from five response options. For 
Visual Puzzles, the participant views a completed puzzle and selects three response 
options that reconstruct the puzzle, within specified time limits. For Symbol Search, the 
participant scans a search group and indicates whether one of the symbols in the target 
group matches within a time limit of 120 seconds. For Coding, the participant uses a key 
to copy symbols that are paired with numbers within a time limit of 120 seconds.  
Children’s Memory Scale (CMS)  
The CMS is a measure used to assess children’s memory abilities and can be used 
for those 5 to 16 years of age (Cohen, 1997). The instrument is designed to assess the 
learning and memory systems, specifically the declarative memory system. It has a total 
of six core subtests. Learning and memory of the auditory/verbal domain is assessed by 
 NEUROPSYCHOLOGICAL FUNCTIONING FOR PBT SURVIVORS                    60 
 
three subtests (Stories, Word Pairs, Word Lists), and the visual/nonverbal domain is 
assessed by another three subtests (Dot Locations, Faces, Family Pictures). Each subtest 
has a mean of 10 and standard deviation of 3. The long-delay scores for Dot Locations 
and Faces subtests were used in the current study to assess an individual’s visual-memory 
abilities. Zureick et al. (2018) also used CMS Dot Locations to assess visual-memory 
abilities for individuals treated for PBTs.  
For Dot Locations, the participant is presented with an array of dots over a set of 
three learning trials and asked to recall the location of dots. A distractor array of dots is 
shown, and then recall of the original dot array follows. At the delay (30 minutes), the 
examinee is asked to recall the original dot array. This subtest specifically measures the 
ability to learn and recall the spatial locations of the dot array. The Faces subtest assesses 
the ability to remember and recognize a series of faces.  For this subtest, the immediate 
portion involves each participant being presented with a series of faces and asked to 
remember them. During the immediate and delayed (30 minutes) portions, the participant 
is shown the same faces along with distractor faces and asked to identify each face as 
either a face he or she was asked to remember, or not.  
Wide Range Assessment of Memory and Learning – Second Edition (WRAML-2)  
 WRAML-2 is a measure used to assess memory functioning and learning in those 
aged 5 through 90 years (Sheslow & Adams, 2004). Six core subtests comprise the core 
battery, which yields three indices – Verbal Memory Index (Story Memory, Verbal 
Learning), Visual Memory Index (Picture Memory, Design Memory), and 
Attention/Concentration Index (Finger Windows, Number Letter). Each subtest has a 
scaled score mean of 10 and standard deviation of 3.    
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The subtest used in the current study is Story Memory Delayed Recall to 
investigate a participant’s long-term verbal contextual memory abilities. This subtest 
requires the participant to remember details and main ideas from two stories read aloud. 
The participant is then asked to recall these stories approximately 20 to 30 minutes later. 
A recognition task of the information is included as well. This subtest is used to evaluate 
auditory memory of meaningful verbal information within a context.  
California Verbal Learning Test – Children’s Version (CVLT-C)  
The CVLT-C is a measure used to assess auditory verbal memory and learning 
abilities for those 5 years through 16 years, 11 months of age (Delis, Kramer, Kaplan, & 
Ober, 1994). The test measures short- and long-term memory performance by using 
familiar categories, such as items on a shopping list. The Free Recall Long Delay was 
used in statistical analysis for this study to assess long-term verbal memory and 
information retrieval.  An overall T score is determined (M = 50; SD = 10) to assess 
immediate recall across the five presentations of the word list.  Z scores (M = 0; SD = 1) 
are used to quantify recall and recognition abilities of the original list. The CVLT-C is 
often used to assess short-term and long-term memory for survivors of PBTs (Reeves et 
al., 2006). 
Five learning trials of 15 words can be organized into three categories. The list is 
read aloud to the participant for a total of five times, with the participant recalling as 
many words as he or she can after each trial. Then, a distractor list is given once before 
asking the individual to recall words from the first list (Short Delay Free Recall). 
Categories of the objects are used as a cue for individuals to recall the original list of 
words (Short Delay Cued Recall). From here, after a 20-minute delay, the participant is 
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asked to recall the original list (Long Delay Free Recall). Then, he or she is cued from 
categories (Long Delay Cued Recall) and finally a recognition task is completed.  
California Verbal Learning Test – Second Edition (CVLT-II)  
The CVLT-II is a measure used to assess auditory verbal memory and learning 
abilities for those 16 through 89 years of age (Delis, Kramer, Kaplan, & Ober, 2000). 
This test measures short- and long-term memory performance by using familiar 
categories. The Free Recall Long Delay was used in statistical analysis for the current 
study to assess long-term verbal memory and retrieval. A T score is determined (M = 50; 
SD = 10) for the overall recall across the five trials. Z scores (M = 0; SD = 1) are used for 
recall and recognition scores. 
Five learning trials of 16 words can be organized into four categories. The list of 
words is read aloud to the participant for a total of five times, with the participant 
recalling as many words as he or she can after each trial (free recall). Then, an 
interference list is presented before asking the participant to recall the original list (Short 
Delay Free Recall), and then the participant is prompted with word categories (Short 
Delay Cued Recall). After 20 minutes, the participant is asked to recall the original list 
(Long Delay Free Recall), cued to the categories again (Long Delay Cued Recall), and 
presented with a recognition task.  
Conners Continuous Performance Test – Second Edition (CPT-II)  
The CPT-II is a computerized assessment of attention-related issues, such as 
sustained attention, impulsivity, and vigilance, for individuals aged 6 years and older 
(Conners, 1995). This measure is often used in research (De Ruiter et al., 2013; Reeves et 
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al., 2006).  Scores are reported in T scores with a mean of 50 and standard deviation of 
10. Higher scores on this measure indicate more deficit (De Ruiter et al., 2013).   
The participant is asked to quickly respond to target letters (all letters except for 
“X”) presented on a computer screen. Total administration time is 14 minutes (Conners, 
2004). A variety of subtest scores is determined from this measure and includes Response 
Times, Changes in Reaction Time Speed and Consistency, Signal Detection, Confidence 
Index, Commissions Errors, and Omissions Errors.  However, the areas of interest for this 
study include inattentiveness (Omissions Errors) and inhibition (Commissions Errors). 
Omissions Errors include the missed targets (non-X targets), and Commissions Errors 
include incorrect responses to nontargets (X).  
Conners Continuous Performance Test – Third Edition (CPT-3)  
The CPT-3 is a computerized assessment of attention-related issues for 
individuals aged 8 years and older (Conners, 2014). Scores are reported in T scores with 
a mean of 50 and a standard deviation of 10. Higher scores on this measure indicate more 
deficits in the area assessed (De Ruiter et al., 2013).  Total administration time is 
approximately 14 minutes, and the participant is asked to quickly respond to target letters 
(i.e., all letters except for “X”) presented on a computer screen (MHS Assessments , 
n.d.). Dimensions assessed include inattentiveness, impulsivity, sustained attention, and 
vigilance. Scores of interest for the current study include Commission Errors (i.e., 
incorrect responses to nontarget) to assess inhibition abilities and Omission Errors (i.e., 
missed targets) to assess inattention abilities.  
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Test of Everyday Attention for Children (TEA-Ch)  
This measure assesses attentional abilities for those aged 6 years to 15 years,11 
months (Manly, Robertson, Anderson, & Nimmo-Smith, 1998). The total of nine subtests 
helps assess children’s and adolescents’ abilities to selectively attend, sustain their 
attention, divide attention between two tasks, switch from one task to another, and 
withhold verbal and motor responses.  Subtests include Sky Search, Map Mission, Score! 
, Score DT, Code Transmission, and Walk, Don’t Walk. Each subtest has a mean of 10 
and a standard deviation of 3.  
For the purposes of this study, Score! and Walk, Don’t Walk subtests were used 
in analysis. Score! is a subtest used to measure sustained auditory attention. It requires 
the participant to count tones silently to him or herself presented at variable intervals for 
10 trials. The participant gives the total number of tones at the end of each trial. The total 
score for this subtest is the number of trials for which the participant gives a correct 
answer, with a maximum raw score of 10. Walk, Don’t Walk is a subtest used to measure 
inhibition abilities with a motor component. For this subtest, participants are given a 
sheet showing 24 paths (four for practice, 20 scored as part of subtest) consisting of 14 
squares. They are asked to listen to a recording in which one tone indicates they should 
“walk” (i.e., make a mark in the square) and another corresponding to the tone of “don’t 
walk” (i.e., don’t mark the square).  The “don’t walk” tone is the “walk” tone with an 
additional sound at the end.  The participant is supposed to mark each square after each 
“walk” tone and inhibit the responses to a “don’t walk” tone, with any mark in the final 
box of the “don’t walk” tone resulting in a trial error.   The raw score is the number of 
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trials for which the participant marked all of the “walk” tones and inhibited a response for 
the “don’t walk” tone.   
Developmental Test of Visual-Motor Integration (VMI)  
The VMI is a paper-and-pencil, –design-copying task for individuals aged 2 years 
to 99 years,11 months old (Beery, & Beery, 2010). The test is used to screen for visual-
motor deficits (Bonner et al., 2009).  Scores are presented as a Standard Score, which has 
a mean of 100 and standard deviation of 15. 
Purdue Pegboard Test  
The Purdue Pegboard Test is an instrument designed to assess fine-motor 
dexterity needed in assembly tasks (Tiffin & Asher, 1948). This test can be used for those 
5 through 89 years of age. Individuals are to place small metal pegs into vertical holes as 
quickly as possible, with a time limit of 30 seconds. The individual is to input the pegs 
first with the dominant hand, then with the nondominant hand, and then lastly using both 
hands. Scores are presented in Standard Scores, which have a mean of 100 and standard 
deviation of 15. The current study used scores from the dominant hand only.  
Procedure 
Permission to conduct this study was obtained from the Institutional Review 
Boards at Children’s Hospital of Philadelphia (CHOP) and Philadelphia College of 
Osteopathic Medicine (PCOM). Permission was also obtained to use the study’s data set.  
Potential participants were identified by exploring the electronic health record (EHR), 
EPIC, for those who had received a neuropsychological evaluation through the Division 
of Oncology at CHOP. The EHR was queried for demographic and disease information 
as well. Results from the neuropsychological evaluation were provided in letter form and 
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were accessible by all EPIC users within the Letters or Media section. As a research 
assistant, the current author entered the data from the neuropsychological evaluations 
found in letter form from EPIC, as well as other demographic and disease information, 
into a database. This data were kept protected using a secured drive on the password-
protected CHOP network.  Each participant was given a participant ID number to 
maintain anonymity, and the list of ID numbers was also kept protected using a secured 
drive on the password-protected CHOP network.  
From this large database, the current author then created a smaller database for the 
current study using inclusion and exclusion criteria. No identifying information was 
transferred to the smaller data set. The deidentified data set was then taken to PCOM to 
be analyzed using SPSS. The analysis included data from various measures discussed in 
the Methods section to investigate differences in the cohort at follow-up. The most recent 
neuropsychological evaluation within the IRB-approved window was used for analysis 
with this cohort, even if there was recurrence prior to neuropsychological evaluation.  
Because the participants in this study ranged from 4 to 28 years of age when they 
underwent neuropsychological evaluations, different versions of measures were used over 
time. Therefore, for statistical analysis, variables were combined to result in one 
combined variable. For example, for the PSI, participants were evaluated using the 
WISC-IV, WISC-V, and WAIS-IV over time. Therefore, scores on these measures were 
combined to make one PSI score across all ages and test versions. This combination to 
one score occurred for VCI, PRI, CVLT Long Delay Free Recall, and CPT Omissions 
Errors and Commissions Errors. 
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Chapter 5: Statistical Analyses and Results 
To evaluate the hypotheses set forth in this study, the planned multivariate 
analyses could not be completed because of the small number of participants and 
extremely low power. Additional analyses were attempted, but the results from these 
analyses were not reported to avoid enhancing the probability of finding a statistically 
significant difference by chance. All statistical analyses were performed using the 
Statistical Package for Social Sciences, version 24 (SPSS 24).  
Between-Group Analyses 
A number of independent t tests were attempted to test differences between 
groups based on age (younger vs. older), proton radiation therapy (PRT) volume (focal 
vs. craniospinal), gender, years since PRT, and pre-existing conditions. However, the 
results of these analyses were not reported because of extremely low power. Instead, the 
groups were described using a standardized psychometric conversion table (see 
Appendix).  
Age  
  The groups were divided using the mean age at diagnosis as a cut-off, which 
Pulsifer et al. (2015) also used. The mean age at diagnosis was found to be 7.8 years (SD 
= 5.45), and the frequency distribution showed that 62.5% of individuals were 7 years old 
or younger. Therefore, the younger group included those participants 7 years old and 
younger (n = 15), while the older group included participants 8 years old and older (n = 
9). See Table 2 for an overview of performance means for these groups.  
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Table 2  
 
Variable Means of the Cohort by Age 
 
Measure Younger 
M(n) 
Older 
M(n) 
 
Verbal Comprehension Index (SS)   95.40 (15) 100.89 (9)  
Perceptual Reasoning Index (SS)  91.62 (13)   98.44 (9)  
Processing Speed Index (SS)   89.38 (13)   83.14 (7)  
CMS Dot Locations Long Delay (ss)    9.85 (13)     7.60 (5)  
CMS Faces Long Delay (ss)     9.31 (13)     8.00 (3) 
WRAML Story Memory Long Delay (ss)   9.85 (13)     9.50 (8) 
CVLT Long Delay Free Recall (z)    0.364 (11)    -1.44 (9)  
Beery VMI (SS)     85.86 (14)   83.00 (9)  
Purdue Pegboard – Dominant (SS)  66.27 (15)   58.22 (9)  
TEA-Ch Walk, Don’t Walk (ss)    5.67 (9)     6.50 (4)  
TEA-Ch Score! (ss)      7.64 (11)      6.60 (5)  
CPT Omissions (T)    54.25 (8)    49.57 (7)  
CPT Commissions (T)   52.75 (8)   48.86 (7)  
Note. SS = Standard Score; ss = scaled score; CMS = Children’s Memory Scale; 
WRAML = Wide Range Assessment of Memory and Learning; CVLT = California 
Verbal Learning Test; z = z-score; VMI = visual motor integration; TEA-Ch = Test of 
Everyday Attention for Children; CPT = Conners Continuous Performance Test; T = T 
score  
 
 
  Descriptively, performance in most domains was relatively intact, ranging from 
Low Average to Average for both the younger and older groups.  Verbal comprehension 
(Verbal Comprehension Index [VCI]) and perceptual reasoning (Perceptual Reasoning 
Index [PRI]) scores were in the Average range for both groups. Additionally, visual facial 
memory (Children’s Memory Scale [CMS] Faces Long Delay), contextual verbal 
memory (Wide Range Assessment of Memory and Learning – Second Edition 
[WRAML-2] Story Memory Long Delay), visual attention and inhibition abilities 
(Connor Continuous Performance Test [CPT] Commission) were all in the Average range 
for both the younger and older group.  Processing speed (Processing Speed Index [PSI]), 
visual-motor integration (Beery-Buktenica Developmental Test of Visual Motor 
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Integration [Beery VMI]), and attention abilities (Test of Everyday Attention for Children 
[TEA-Ch] Score!) were all in the Low Average range for both groups. Dominant-hand 
fine-motor skills (Purdue Pegboard - Dominant) was in the Impaired range for both 
groups. Discrepancies between groups were found in regard to visual spatial memory 
(CMS Dot Locations), where the younger group performed in the Average range, while 
the older group performed in the Low Average range. Regarding verbal list learning and 
memory (California Verbal Learning Test [CVLT] Long Delay Free Recall), the younger 
group performed in the Average range, while the older group performed in the Borderline 
range. Performance on an inhibition variable (TEA-Ch Walk, Don’t Walk) was 
Borderline for the younger group and Low Average for the older group.  
  The majority of the younger group were male patients (80%) who had received 
focal PRT (80%). A total of six individuals (40%) received a diagnosis of a mental-health 
disorder post treatment, and seven individuals (46.7%) had a medical consequence post 
treatment. One participant (6.7%) had one or more pre-existing conditions. The mean 
number of years since PRT was 3.93 (SD = 2.02), with a range of 2 to 10 years.  
      The majority of the older group were also male patients (77.8%) who had received 
focal PRT (66.7%). Four (44.4%) individuals in this group were diagnosed with a mental-
health disorder post treatment, and two individuals (22.2%) had one or more medical 
consequences post treatment. Three individuals (33.3%) had one or more pre-existing 
conditions. Mean number of years since PRT was 3.33 (SD = 1), with a range of 2 to 5 
years.  
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PRT Volume  
  Differences among PRT volumes were investigated. See Table 3 for an overview 
of mean performance for these groups. 
 
Table 3  
 
Variable Means of the Cohort by PRT Volume 
Measure Focal 
M(n) 
Craniospinal 
M (n) 
 
Verbal Comprehension Index (SS)   94.22 (18)    107.17 (6)  
Perceptual Reasoning Index (SS)  93.69 (16)      96.33 (6)   
Processing Speed Index (SS)   87.13 (15)      87.40 (5)  
CMS Dot Locations Long Delay (ss)    9.33 (15)        8.67 (3)   
CMS Faces Long Delay (ss)     9.23(13)        8.33 (3)  
WRAML Story Memory Long Delay (ss)   9.75 (16)        9.60 (5)   
CVLT Long Delay Free Recall (z)    -.600 (15)         .000 (5)   
Beery VMI (SS)    88.24 (17)      74.83 (6)   
Purdue Pegboard – Dominant (SS)  61.56 (18)      68.33 (6)   
TEA-Ch Walk, Don’t Walk (ss)    5.20 (10)        8.33 (3)   
TEA-Ch Score! (ss)      7.31 (13)         7.33 (3)   
CPT Omissions (T)    53.36 (11)       48.50 (4)   
CPT Commissions  (T)   49.36  (11)      55.25 (4)   
Note. PRT = proton radiation therapy; SS = Standard Score; CMS = Children’s Memory 
Scale; ss = scaled score; WRAML = Wide Range Assessment of Memory and Learning; 
CVLT = California Verbal Learning Test; z = z score; VMI = visual motor integration; 
TEA-Ch = Test of Everyday Attention for Children; CPT = Conners Continuous 
Performance Test; T = T score   
 
 
  Descriptively, overall performances in most domains ranged from Low Average 
to Average when dividing the group by PRT volume (focal vs. craniospinal). Verbal 
comprehension (VCI), perceptual reasoning (PRI), visual memory (CMS Dot Location & 
Faces), verbal memory (WRAML-2 Story Memory; CVLT Long Delay Free Recall), and 
inhibition and attentional abilities measured by the CPT (Omissions & Commissions) 
were all in the Average range across both groups. Processing speed (PSI) and attention 
measured by TEA-Ch Score! were in the Low Average range for both groups. Dominant-
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hand fine-motor skill (Purdue Pegboard-Dominant) was in the Impaired range for both 
groups. Differences between groups were seen in regard to an inhibition variable (TEA-
Ch Walk, Don’t Walk), where the focal group performed in the Borderline range, while 
the craniospinal group performed in the Average range. The focal group performed in the 
Low Average range in regard to visual-motor integration (Beery VMI), while the 
craniospinal group performed in the Borderline range.  
Frequencies and means were calculated within the focal group and craniospinal 
group to determine if characteristics were different on a descriptive level. First, the focal 
group was examined. This group consisted of 18 individuals. The majority of these 
individuals was in the younger group (66.7%) and was male (77.8%). In regard to mean 
age at diagnosis, this group had a mean of 6.78 years (SD = 5.16) with a range of 1 to 17 
years of age. Additionally, individuals were on average about 11 (SD = 5.84) years of age 
at the most recent evaluation, with a range of 4 to 28 years of age. The mean years since 
PRT was 3.50 (SD = 1.15), with a range from 2 to 5 years. This group consisted of all 
individuals with a history of one or more pre-existing conditions (n = 4). These four 
people did not have a corresponding posttreatment mental-health diagnosis or medical 
consequence.  Additionally, six (33.3%) individuals had a mental-health diagnosis, and 
six (33.3%) had some kind of medical consequence post treatment. Although some 
overlap exists, the five individuals who received a mental-health diagnosis and had a 
medical consequence post treatment are not the same participants.  
 The craniospinal group had a total of six individuals. The groups were evenly split 
in terms of age group (younger vs. older). The majority of the group was male (83.3%). 
Mean age at diagnosis for this group was 10.8 years (SD = 5.68), with a range of 5 to 19 
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years of age, and mean age at most recent evaluation was 15.50 years (SD = 4.81), with a 
range of 10 to 22 years of age. The mean number of years since PRT was 4.33 (SD = 
2.88), with a range of 2 to 10 years. A total of four individuals (66.7%) were diagnosed 
with a mental-health disorder, and three individuals (50%) had a medical consequence 
post treatment. Although some overlap exists, the four individuals with a mental-health 
diagnosis are not the same individuals who had a medical consequence. No individuals in 
this group had a pre-existing condition.  
Follow-Up Comparisons   
  The group was divided by follow-up years to determine whether differences in 
performance existed on a descriptive level. The mean number of years post PRT for the 
whole cohort was 3.7 (SD = 1.71). Additionally, looking at the frequency distribution, 
54.2% of participants were 3 years or fewer  post PRT. Therefore, the group was divided 
with 3 or fewer years post PRT versus 4 or more years post PRT. See Table 4 for an 
overview of means for the group.  
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Table 4  
Variable Means of the Cohort by Follow-Up  
Measure 3 or fewer yrs 
M(n) 
4 or more yrs 
M (n) 
 
Verbal Comprehension Index (SS)   98.85 (13)    95.82 (11)  
Perceptual Reasoning Index (SS)  98.64 (11)    90.18 (11)   
Processing Speed Index (SS)   88.36 (11)    85.78 (9)  
CMS Dot Locations Long Delay (ss)    9.30 (10)      9.13 (8)   
CMS Faces Long Delay (ss)   10.56 (9)      7.14 (7)  
WRAML Story Memory Long Delay (ss) 10.64 (11)      8.70 (10)   
CVLT Long Delay Free Recall (z)     -.318 (11)       -.611(9)   
Beery VMI (SS)    91.67 (12)    77.18(11)   
Purdue Pegboard – Dominant (SS)  64.77 (13)    61.45 (11)   
TEA-Ch Walk, Don’t Walk (ss)    6.86 (7)      4.83 (6)   
TEA-Ch Score! (ss)      6.63 (8)       8.00 (8)   
CPT Omissions (T)    52.44 (9)     51.50 (6)   
CPT Commissions  (T)   51.44 (9)    50.17 (6)   
Note. SS = Standard Score; CMS = Children’s Memory Scale; ss = scaled score; 
WRAML = Wide Range Assessment of Memory and Learning; CVLT = California 
Verbal Learning Test; z = z score; VMI = visual motor integration; TEA-Ch = Test of 
Everyday Attention for Children; CPT = Conners Continuous Performance Test; T = T 
score   
 
 
  The groups performed in the Average range in regard to verbal comprehension 
(VCI), perceptual reasoning (PRI), visual spatial memory (CMS Dot Locations), verbal 
memory (WRAML-2 Story Memory, CVLT Free Recall Long Delay), and inhibition and 
attention abilities measured by CPT (Omissions & Commissions). The group performed 
in the Low Average range in regard to processing speed (PSI). Furthermore, the groups 
performed in the Impaired range in regard to dominant-hand fine-motor skills (Purdue 
Pegboard- Dominant).The groups differed in performance in regard to visual facial 
memory (CMS Faces), where the group with 3 or fewer years since follow-up scored in 
the Average range, while the group with 4 or more years since follow-up scored in Low 
Average range. Additionally, the group with 3 or fewer years since follow-up performed 
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in the Average range in regard to visual-spatial integration (Beery VMI), while the group 
with 4 or more years since follow-up performed in the Borderline range. The group with 
3 or fewer years since follow-up scored in the Low Average range on an inhibition 
variable (TEA-Ch Walk, Don’t Walk), while the group with 4 or more years since 
follow-up performed in the Borderline range. The group with 3 or fewer years since 
follow-up scored in the Low Average range on an attention variable (TEA-Ch Score!), 
while the group with 4 or more years since follow-up performed in the Average range.  
  A total of 13 individuals were 3 or fewer years post PRT. The majority of 
individuals in this group were male (76.9%) and had received focal PRT (76.9%). Mean 
age at diagnosis for this group was 8.38 years (SD = 5.27), with a range of 1 to 17 years 
of age. Mean age at most recent evaluation was 11.85 years (SD = 6.50), with a range of 
4 to 28 years of age. Four participants (30.8%) were diagnosed with a mental-health 
disorder post PRT, and three participants (23.1%) had a medical consequence of 
treatment. A total of three participants (23.1%) had one or more pre-existing conditions.  
  A total of 11 individuals were 4 or more years post PRT. The majority of 
individuals in this group were male (81.8%) and had received focal PRT (72.7%). Mean 
age at diagnosis of this group was 7.09 years (SD = 5.84), with a range of 1 to 19 years of 
age. Mean age at most recent evaluation was 12.45 years (SD =  5.26), with a range of 6 
to 22 years of age. Six participants received a mental-health diagnosis post treatment 
(54.5%), and six participants had a medical consequence of treatment (54.5%). Two 
participants had one or more pre-existing conditions (36.4%).  
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Gender Comparisons  
  The cohort was also investigated by comparing means by gender. This cohort was 
male dominant (n = 19). However, making this comparison adds to the descriptive data of 
the whole cohort. Table 5 shows an overview of these means for the cohort.   
 
Table 5  
Variable Means of the Cohort by Gender 
Measure Male 
M(n) 
Female  
M (n) 
 
Verbal Comprehension Index (SS)   96.74 (19)    100.20 (5)  
Perceptual Reasoning Index (SS)  95.24 (17)      91.60 (5)   
Processing Speed Index (SS)   87.00 (15)      87.80 (5)  
CMS Dot Locations Long Delay (ss)    9.40 (15)        8.33 (3)   
CMS Faces Long Delay (ss)     8.50 (14)      13.00 (2)  
WRAML Story Memory Long Delay (ss)   9.47 (17)      10.75 (4)   
CVLT Long Delay Free Recall (z)     -.500 (16)        -.250 (4)   
Beery VMI (SS)    86.28 (18)      79.20 (5)   
Purdue Pegboard – Dominant (SS)  62.00 (19)      68.00 (5)   
TEA-Ch Walk, Don’t Walk (ss)    5.64 (11)        7.50 (2)   
TEA-Ch Score! (ss)      7.62 (13)         6.00 (3)   
CPT Omissions (T)    52.17 (12)       51.67 (3)   
CPT Commissions  (T)   48.75 (12)      59.67 (3)   
Note.SS = Standard Score; CMS = Children’s Memory Scale; ss = scaled score; 
WRAML = Wide Range Assessment of Memory and Learning; CVLT = California 
Verbal Learning Test; z = z score; VMI = visual motor integration; TEA-Ch = Test of 
Everyday Attention for Children; CPT = Conners Continuous Performance Test; T = T 
score   
 
 
  Both male and female individuals performed in the Average range in regard to 
verbal comprehension (VCI), perceptual reasoning (PRI), visual spatial memory (CMS 
Dot Locations), verbal memory (WRAML-2 Story Memory, CVLT Long Delay Free 
Recall), and attention and inhibition abilities (CPT Commissions & Omissions).  Both 
groups performed in the Low Average range in regard to processing speed (PSI). 
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Additionally, both groups performed in the Impaired range in regard to dominant-hand 
fine-motor skills (Purdue Pegboard - Dominant). Group differences in performance were 
found in regard to visual facial memory (CMS Faces), where male individuals performed 
in the Average range and female individuals scored in the High Average range. Male 
individuals performed in the Low Average range in regard to visual spatial integration 
(Beery VMI), while female individuals performed in the Borderline range. Additionally, 
male individuals performed in the Borderline range in regard to inhibition abilities (TEA-
Ch Walk, Don’t Walk), while female individuals performed in the Low Average range. 
Mal individuals scored in the Low Average range on an attention variable (TEA-Ch 
Score!), while female individuals performed in the Borderline range.  
 The majority of the male group (n = 19) received focal PRT (73.7%). Mean age at 
diagnosis for male individuals was 7.47 years (SD = 5.47), with a range of 1 to 19 years 
of age. Mean age at most recent evaluation was 11.26 years (SD = 5.15), with a range of 
4 to 22 years. Mean years since PRT was 3.53 (SD = 1.02), with a range of 2 to 5 years. 
Nine individuals received a mental-health diagnosis post treatment (47.4%), while seven 
individuals (36.8%) had a medical consequence of treatment. Three male individuals had 
one or more pre-existing conditions (15.8%).  
 The majority of the female group (n = 5) also received focal PRT (80%). Mean 
age at diagnosis was 9.00 years (SD = 5.83), with a range of 3 to 17 years of age. Mean 
age at most recent evaluation was 15.40 years (SD  = 7.77), with a range of 9 to 28 years 
of age. Lastly, the group was, on average, 4.40 years (SD = 3.36) post treatment with 
PRT, with a range of 2 to 10 years. One individual (20%) had a medical consequence 
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post treatment and received a mental-health diagnosis post treatment. A different 
individual had one or more pre-existing conditions (20%).   
Preexisting Conditions Comparisons  
  The variable means of the cohort was also investigated by looking at the impact of 
pre-existing conditions. Although only four participants had one or more pre-existing 
conditions, these comparisons are descriptive only and used to determine whether a trend 
in the data may exist. Some comparisons had a group consisting of one to two people, so 
these results need to be viewed with caution. See Table 6 for an overview of these means.  
 
Table 6  
Variable Means of the Cohort by Pre-Existing Conditions  
Measure No 
M(n) 
Yes 
M (n) 
 
Verbal Comprehension Index (SS)   97.90 (20)      95.25 (4)  
Perceptual Reasoning Index (SS)  92.50 (18)    103.00 (4)   
Processing Speed Index (SS)   88.56 (16)      81.75 (4)  
CMS Dot Locations Long Delay (ss)    9.60 (15)        7.33 (3)   
CMS Faces Long Delay (ss)     8.87 (15)      12.00 (1)  
WRAML Story Memory Long Delay (ss)   9.94 (18)        8.33 (3)   
CVLT Long Delay Free Recall (z)    0.00 (16)       -2.25 (4)   
Beery VMI (SS)    83.32 (19)      91.50 (4)   
Purdue Pegboard – Dominant (SS)  66.35 (20)      47.75 (4)   
TEA-Ch Walk, Don’t Walk (ss)    6.18 (11)        4.50 (2)   
TEA-Ch Score! (ss)      8.07 (13)         4.00 (3)   
CPT Omissions (T)    52.83 (12)       49.00 (3)   
CPT Commissions  (T)   53.83 (12)      39.33 (3)    
Note. SS = Standard Score; CMS = Children’s Memory Scale; ss = scaled score; 
WRAML = Wide Range Assessment of Memory and Learning; CVLT = California 
Verbal Learning Test; z = z score; VMI = visual motor integration; TEA-Ch = Test of 
Everyday Attention for Children; CPT = Conners Continuous Performance Test; T = T 
score   
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  Overall, the two groups performed in the Average range in regard to verbal 
comprehension (VCI), perceptual reasoning (PRI), visual spatial memory (CMS Faces), 
verbal contextual memory (WRAML-2 Story Memory), and attention (CPT Omissions). 
Both groups performed in the Low Average range in regard to processing speed (PSI). 
Both groups performed in the Borderline range in regard to inhibition (TEA-Ch Walk, 
Don’t Walk) and in the Impaired range in regard to dominant-hand fine-motor skills 
(Purdue Pegboard - Dominant). The groups differed in regard to visual spatial memory 
(CMS Dot Locations) in that the group with pre-existing conditions performed in the 
Low Average range while the group without pre-existing conditions performed in the 
Average range. The group with pre-existing conditions performed in the Impaired range 
in regard to verbal list learning (CVLT Long Delay Free Recall), while the group without 
pre-existing conditions performed in the Average range. The group with pre-existing 
conditions performed in the Average range in regard to visual spatial integration (Beery 
VMI), while the group without pre-existing conditions performed in the Low Average 
range. The group with pre-existing conditions performed in the Borderline range in 
regard to attention abilities (TEA-Ch Score!), while the group without pre-existing 
conditions performed in the Average range. Furthermore, the pre-existing conditions 
group performed in the Low Average range in regard to inhibition (CPT Commissions), 
while the group without pre-existing conditions performed in the Average range.  
   Of the four participants with a pre-existing condition, three individuals were male 
(75%) and one was female (25%). Mean age at diagnosis for this group was 11.25 years 
(SD = 4.27), with a range of 6 to 16 years of age. Mean age at most recent evaluation was 
14.50 years (SD = 4.12), with a range of 9 to19 years. Furthermore, the group was on 
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average 3.25 years post PRT (SD = 1.26), with a range of 2 to 5 years. All four 
individuals (100%) received focal PRT. None of the individuals had a medical 
consequence or received a mental-health diagnosis post treatment.  
Within-Group Analyses 
To determine whether differences between what was observed and what was 
expected for each variable across the participant cohort existed, a number of chi-square 
analyses were attempted. Overall, an attempt was made to determine whether a 
relationship existed between age and performance on the neuropsychological measures. 
Also, an attempt was made to see if a relationship between demographic variables (PRT 
volume, gender, PRT dose, years since PRT, pre-existing conditions) and performance on 
neuropsychological measures existed. However, large differences between frequencies of 
most variables were noted. Because of the extremely low power and multiple statistical 
analyses needed and the enhanced likelihood of finding a difference by chance even with 
a Bonferroni correction, the chi-square analyses were not reported. Instead, a descriptive 
approach was used to describe the within-group differences of the cohort based on age 
and PRT volume.  
  For these comparisons, demographic variables (i.e., age at diagnosis and PRT 
volume) were coded into binary variables. The individuals were divided into two age 
groups (i.e., younger vs. older) in regard to age at diagnosis. The mean age at diagnosis 
was found to be 7.8 years (SD = 5.45), and the frequency distribution showed that 62.5% 
of individuals were aged 7 years or younger. Therefore, the younger group included those 
individuals 7 years old and younger (n = 15), while the older group included individuals 
8 years old and older (n = 9). Pulsifer et al. (2015) also used this approach when dividing 
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their participant group by age. The group was also divided by PRT volume (i.e., focal vs. 
craniospinal). Again, the focal group included 18 individuals while the craniospinal 
group included six individuals.  
The test-related performance variables were also coded into binary variables. A 
cut-off of 1 standard deviation was used to indicate “below average” versus “average” 
functioning. For the measures that use Standard Scores (SS; M = 100; SD = 15), any 
score equal to or below 1 standard deviation below the mean (SS = 85) was coded as 
below average. Any score equal to or above a SS of 86 was coded as average. For the 
measures that used scaled scores (ss; M = 10; SD = 3), a score equal to or lower than 7 
was coded as below average, while a score equal to or greater than 8 was coded as 
average. For measures that used z scores (M = 0; S D =1), a score equal to or less than -
1.0 was coded as below average, and a score greater than -1.0 was coded as average. The 
CPT was the only measure that used a T score (M = 50; SD = 10). Because higher scores 
on this measure indicate more deficit, any score equal to or greater than 1 standard 
deviation above the mean (T = 60) was coded as below average, and any score equal to or 
below 59 was scored as average.  
To describe within-group differences, the groups were divided by age (i.e., 
younger vs. older). Then each group’s performance was investigated to determine 
frequency of participants in each category (i.e., below average vs. average) for those who 
received focal PRT versus those who received craniospinal PRT. So, the group was 
described as younger/focal comparisons and then younger/craniospinal comparisons. 
Additionally, the older group was then investigated in the same way. The group was 
described as older/focal comparisons and then older/craniospinal comparisons. 
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Younger/Focal Group Comparisons  
  A total of 12 individuals were in this group. Descriptively, a total of two variables 
were in the below average range for the majority (> 50%) of the sample. These variables 
included fine-motor skills (Purdue Pegboard - Dominant; n = 12) and inhibition abilities 
(TEA-Ch Walk/Don’t Walk; n = 7).  
       The majority (> 50%) of the sample performed in the average range in regard to 
verbal comprehension (VCI), perceptual reasoning (PRI), processing speed (PSI), visual 
memory (CMS Dot Locations, Faces), verbal memory (WRAML-2 Story Memory, 
CVLT Long Delay Free Recall), visual-motor integration (Beery VMI), attention abilities 
(TEA-Ch Score), and inhibition abilities (CPT Commission). The groups were evenly 
distributed in regard to attention abilities (CPT Omissions). See Table 7 for an overview 
of percentages.  
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Table 7 
 
Percentage of Below Average vs. Average Functioning for Younger Group Treated with 
Focal PRT 
Variable (N) Below Avg (%)  Average (%)  
Verbal Comprehension Index (12)  33.3 66.7 
Perceptual Reasoning Index (10)           20          80 
Processing Speed Index (10)           30          70 
CMS Dot Locations Long Delay (11) 18.2 81.8 
CMS Faces Long Delay (11) 27.3 72.7 
WRAML Story Memory Long Delay (11) 18.2 81.8 
CVLT Long Delay Free Recall (9) 33.3 66.7 
Beery VMI (11) 18.2 81.8 
Purdue Pegboard – Dominant (12)           75          25 
TEA-Ch Walk, Don’t Walk (7) 71.4 28.6 
TEA-Ch Score! (9) 44.4 55.6 
CPT Omissions (6)           50          50 
CPT Commissions  (6) 33.3 66.7 
Note. PRT = proton radiation therapy; CMS = Children’s Memory Scale;  WRAML = 
Wide Range Assessment of Memory and Learning; CVLT = California Verbal Learning 
Test; VMI = visual motor integration; TEA-Ch = Test of Everyday Attention for 
Children; CPT = Conners Continuous Performance Test 
 
 
Younger/Craniospinal Group Comparisons  
  A total of three individuals were in this group. Descriptively, a total of two 
variables were in the below average range for the majority (> 50%) of participants who 
were in the younger group and received focal PRT. These variables included visual-
motor abilities (Beery VMI; n = 3) and fine-motor skills (Purdue Pegboard - Dominant; n 
= 3). 
  The majority (> 50%) performed in the average range in regard to verbal 
comprehension (VCI), perceptual reasoning abilities (PRI), processing speed (PSI), visual 
memory for faces (CMS Faces), verbal memory (WRAML-2 Story Memory, CVLT 
Long Delay Free Recall), and attention abilities (CPT Omissions). The group was evenly 
split in regard to visual spatial memory (CMS Dot Locations), inhibition (TEA-Ch Walk, 
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Don’t Walk, CPT Commissions), and attention (TEA-Ch Score!). See Table 8 for an 
overview of percentages.  
 
Table 8  
 
Percentage of Below Average vs. Average Functioning for Younger Group Treated with 
Craniospinal PRT 
Variable (N) Below Avg (%) Average (%) 
Verbal Comprehension Index (3)  33.3 66.7 
Perceptual Reasoning Index (3) 33.3 66.7 
Processing Speed Index (3) 33.3 66.7 
CMS Dot Locations Long Delay (2)           50          50 
CMS Faces Long Delay (2) 0        100 
WRAML Story Memory Long Delay (2) 0        100 
CVLT Long Delay Free Recall (2) 0        100 
Beery VMI (3)          100 0 
Purdue Pegboard – Dominant (3)          100 0 
TEA-Ch Walk, Don’t Walk (2) 50           50 
TEA-Ch Score! (2) 50           50 
CPT Omissions (2)   0         100 
CPT Commissions  (2) 50 50 
Note. PRT = proton radiation therapy; CMS = Children’s Memory Scale;  WRAML = 
Wide Range Assessment of Memory and Learning; CVLT = California Verbal Learning 
Test; VMI = visual motor integration; TEA-Ch = Test of Everyday Attention for 
Children; CPT = Conners Continuous Performance Test 
 
Older/Focal Group Comparisons  
  A total of six individuals were in this group. Descriptively, a total of six variables 
were in the below average range for the majority (> 50%) of participants who were in the 
older group and received focal PRT. These variables included processing speed (PSI; n = 
5), visual spatial memory (CMS Dot Locations; n = 5), visual-motor abilities (Beery 
VMI; n = 6), fine-motor skills (Purdue Pegboard - Dominant;  n = 6), inhibition abilities 
(TEA-Ch Walk, Don’t Walk; n = 3), and attention abilities (TEA-Ch Score; n = 4).  
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  The majority (> 50%) performed in the average range in regard to verbal 
comprehension (VCI), perceptual reasoning abilities (PRI), contextual verbal memory 
(WRAML-2 Story Memory), and inhibition and attention abilities measured by the CPT 
(CPT Omissions & Commissions). The group was evenly split in regard to visual 
memory for faces (CMS Faces) and verbal list memory (CVLT Long Delay Free Recall). 
See Table 9 for an overview of percentages.  
 
Table 9 
 
 Percentage of Below Average vs. Average Functioning for Older Group Treated with 
Focal PRT 
Variable (N) Below Avg (%) Average (%) 
Verbal Comprehension Index (6)   16.7    83.3 
Perceptual Reasoning Index (6)   33.3    66.7 
Processing Speed Index (5) 80 20 
CMS Dot Locations Long Delay (4) 75 25 
CMS Faces Long Delay (2) 50 50 
WRAML Story Memory Long Delay (5) 20 80 
CVLT Long Delay Free Recall (6) 50 50 
Beery VMI (6)     83.3    16.7 
Purdue Pegboard – Dominant (6)     83.3    16.7 
TEA-Ch Walk, Don’t Walk (3)          100   0 
TEA-Ch Score! (4) 75 25 
CPT Omissions (5) 20 80 
CPT Commissions  (5) 20 80 
Note. PRT = proton radiation therapy; CMS = Children’s Memory Scale;  WRAML = 
Wide Range Assessment of Memory and Learning; CVLT = California Verbal Learning 
Test; VMI = visual motor integration; TEA-Ch = Test of Everyday Attention for 
Children; CPT = Conners Continuous Performance Test 
 
 
Older/Craniospinal Group Comparisons  
This group included three individuals, with only one or two individuals completing some 
measures. Nonetheless, a total of three variables was considered below average for the 
majority (> 50%) of the participants in the older group who had received craniospinal 
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PRT. These variables included visual memory for faces (CMS Faces; n = 1), fine-motor 
skills (Purdue Pegboard - Dominant; n = 3), and attentional abilities (TEA-Ch Score; n = 
1).  
The majority (> 50%) of the group performed in the average range in regard to 
verbal comprehension (VCI), perceptual reasoning (PRI), visual spatial memory (CMS 
Dot Locations), verbal memory (WRAML-2 Story Memory, CVLT Long Delay Free 
Recall), visual motor integration (Beery VMI), inhibition abilities (TEA-Ch Walk, Don’t 
Walk, CPT Commissions), and attention abilities (CPT Omissions). The group was 
evenly split in regard to processing speed (PSI). See Table 10 for an overview of 
percentages.   
 
Table 10  
 
Percentage of Below Average vs. Average Functioning for Older Group Treated with 
Craniospinal PRT 
Variable (N) Below Avg (%) Average (%) 
Verbal Comprehension Index (3)    0 100 
Perceptual Reasoning Index (3)   0 100 
Processing Speed Index (2) 50   50 
CMS Dot Locations Long Delay (1)   0 100 
CMS Faces Long Delay (1)          100     0 
WRAML Story Memory Long Delay (3)    33.3      66.7 
CVLT Long Delay Free Recall (3)    33.3      66.7 
Beery VMI (3)    33.3      66.7 
Purdue Pegboard – Dominant (3)    66.7      33.3 
TEA-Ch Walk, Don’t Walk (1)   0 100 
TEA-Ch Score! (1)          100    0 
CPT Omissions (2)   0 100 
CPT Commissions (2)   0 100 
Note. PRT = proton radiation therapy; CMS = Children’s Memory Scale; WRAML = 
Wide Range Assessment of Memory and Learning; CVLT = California Verbal Learning 
Test; VMI = visual motor integration; TEA-Ch = Test of Everyday Attention for 
Children; CPT = Conners Continuous Performance Test 
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Exploratory Correlation Analyses 
 Using the hypotheses as a guide, a number of Pearson correlations were 
conducted between neuropsychological performance variables to determine if certain 
relationships existed. Therefore, correlations were conducted for cognitive variables (i.e., 
VCI, PRI), visual-memory variables (CMS Dot Locations & Faces), verbal-memory 
variables (WRAML-2 Story Memory, CVLT Long Delay Free Recall), visual-
motor/processing speed variables (Beery VMI, Purdue Pegboard - Dominant, PSI), 
attention variables (TEA-Ch Score & CPT Omissions), and inhibition variables (TEA-Ch 
Walk, Don’t Walk & CPT Commissions). A number of significant correlations were 
found and will be reviewed. Because multiple analyses (total of 10 correlations) were 
conducted, a Bonferroni correction was used. The new conservative p value was set at p 
< .005.  
A significant correlation was found between the VCI and PRI, r = .627, p = .002. 
A partial correlation was conducted to control for time (years since PRT), and the two 
variables did not remain correlated, r = .591, p = .005, using the conservative Bonferroni 
correction. Thus, time had an effect on this relationship, indicating that as time went on, 
these scores were no longer correlated. Thus, performance on these two variables began 
to differ slightly.  
 A significant correlation was found between PSI and Purdue Pegboard - 
Dominant scores, r = 0.690, p = .001, indicating higher scores on one variable was highly 
correlated with higher scores on the other variable. A partial correlation was then 
conducted to control for years since PRT, and the relationship continued to be significant, 
r = .700, p = .001, indicating that the passage of time had no effect on the relationship. 
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Another significant correlation was found between PSI and Beery VMI, r = .706, p = 
.001, indicating higher scores on one variable was moderately correlated with higher 
scores on the other. This relationship also remained significant when controlling for time 
since PRT, r = .780, p = .000, indicating time had no effect on the relationship. 
Therefore, these variables (i.e., PSI, Purdue Pegboard, Beery VMI) are measuring 
constructs with similar aspects (i.e., fine-motor component).  See Table 11 for an 
overview of these correlations. 
 
Table 11  
Summary of Significant Correlations for Neuropsychological Performance Variables  
Measure 1. 2. 3. 4. 5. 
1. VCI ---- .627** ---- ---- ---- 
2. PRI .627** ---- ---- ---- ---- 
3. PSI ---- ---- ---- .690** .706** 
4. Purdue Pegboard-Dominant ---- ---- .690** ---- n.s.a 
5. Beery VMI  ---- ---- .706** n.s.a ---- 
Note. VCI = Verbal Comprehension Index; PRI = Perceptual Reasoning Index; PSI = 
Processing Speed Index; VMI = visual motor integration 
** p < .005. an.s. = not significant. 
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Chapter 6: Discussion 
Summary and Integration of Findings 
 The primary goal of the present study was to examine the influence of age at 
diagnosis on neuropsychological functioning for children and adolescents treated with 
proton radiation therapy (PRT) for their infratentorial pediatric brain tumors (PBTs). It 
was hypothesized that younger individuals would perform poorer than older individuals 
on measures of verbal comprehension, perceptual reasoning, verbal and visual memory, 
processing speed, visual-motor functioning, and attention and inhibition. The overall 
number of individuals was below the typical rule for adequate statistical power given the 
planned analyses, so the results of the analyses were not reported. Instead, a descriptive 
approach was implemented to describe the cohort.  
Age  
The younger group contained individuals 7 years old and younger, while the older 
group contained individuals 8 years old and older. Descriptively, the younger and older 
groups’ performances were relatively intact and ranged from Low Average to Average. 
Performance in terms of verbal comprehension, perceptual reasoning, facial memory, 
contextual verbal memory, and visual attention and inhibition was in the Average range, 
while performance in regard to processing speed, auditory attention, and visual-motor 
integration was in the Low Average range. Additionally, both groups performed in the 
Impaired range on dominant-hand fine-motor skills. The groups differed in performance 
on visual spatial memory, verbal list learning, and auditory inhibition abilities.  
Although a greater number of participants was in the younger group, the younger 
group actually appeared to perform better compared to the older group overall.  Although 
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some research has found a positive correlation between age at diagnosis and cognitive 
functioning, others have stated that the effect of age is largely unclear (De Ruiter et al., 
2013; Patel et al., 2011). The effect of age on performance post PRT in the current study 
also remains unclear, unfortunately. Because deficits may be delayed after PRT, it was 
hypothesized that the younger group may have performed better because their years since 
PRT were fewer than the years for the older group. However, the younger group was on 
average 3.93 years post PRT, while the older group was 3.33 years post PRT, which is 
consistent. Therefore, determining the impact of time since PRT or age at diagnosis is not 
possible for this group.  
Additionally, one important factor regarding the impact of age for this cohort 
includes the number of individuals in each group. A total of 15 individuals were in the 
younger group, while a total of nine individuals were in the older group. Therefore, group 
performances could have been inflated or deflated based on individuals in the specific 
groups. For instance, if a few individuals who were exceptionally high functioning were 
in the younger group, their functioning could have pulled the mean higher. The converse 
could also be true; if a few individuals in the older group had been extraordinarily low 
functioning, they could have pulled the mean down overall. Looking at the ranges of 
scores, as well as the median for each variable across the younger and older groups, the 
older group appeared to have individuals with lower functioning on the majority of the 
variables. Because no comparison was made from baseline to follow-up, controlling for 
premorbid functioning is impossible. Participant characteristics were consistent in terms 
of mental-health diagnoses and medical consequences post PRT for both groups; thus, 
determining whether these issues could have affected performance is difficult as well.  
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Because no concrete comparisons could be identified comparing the group by age, 
the current study examined the cohort in a number of different ways.  
PRT Volume 
 When comparing the groups by PRT volume (focal vs. craniospinal), the groups 
performed largely in the Average or Low Average range. Both groups performed in the 
Average range in regard to verbal comprehension, perceptual reasoning, visual memory, 
verbal memory, and visual attention and inhibition abilities measured by a computerized 
attention measure (Connor Continuous Performance Test [CPT]). Both groups performed 
in the Low Average range in regard to processing speed and an auditory measure of 
attention. Consistent with the age groups, both PRT volume groups performed in the 
Impaired range on dominant-hand fine-motor skills. The focal and craniospinal groups 
differed in performance in terms of visual-motor integration and auditory inhibition 
abilities. 
 Interestingly, both PRT volume groups performed consistently in the same ranges 
for a majority of the variables. Although these analyses are just descriptive, the 
consistency of performance across groups is in contrast to findings in previous research 
(Antonini et al., 2017). Antonini et al. (2017) found that craniospinal PRT was a risk 
factor for their participant cohort and led to more deficits. The reasoning behind such a 
finding relates to radiation exposure to more areas of the brain. Thus, more areas would 
be affected, leading to more diverse deficit. Ventura et al. (2018) also found similar 
findings in which some domains, such as processing speed and working memory, were 
significantly related to those who received craniospinal PRT.  
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Again, the sample size in the current study was very small, and therefore, the 
number of people possibly was insufficient to parse out differences between groups 
relating to PRT volume. Additionally, participants in the craniospinal group were older at 
diagnosis and were 4.33 years post PRT. In comparison, individuals in the focal group 
were 3.5 years post PRT. Therefore, the craniospinal group might not have performed as 
expected because the participants were older when they were diagnosed and older at the 
most recent evaluation, aligning with previous research that indicates young age as a risk 
factor (De Ruiter et al., 2013; Levisohn et al., 2000; Wolfe et al., 2012). Furthermore, 
craniospinal RT is generally avoided in younger individuals as a result of known 
morbidity (Nelson et al., 2013; Semenova, 2009).  
Much like the age groups, the PRT volume groups were unequal in size, with the 
focal group including 18 participants, and the craniospinal group including six 
participants. Again, this small sample size was likely not sensitive enough to determine 
differences between the groups based on performance variables (i.e., neuropsychological 
measures).  Additionally, the focal group contained all four participants with a pre-
existing condition, but the craniospinal group had a higher percentage of individuals with 
a mental-health diagnosis post PRT. Again, hypothesizing whether these factors 
influenced group mean performance is difficult.  
 PRT volume was investigated further by controlling for age. Again, the younger 
group contained individuals 7 years of age and younger while the older group contained 
individuals 8 years of age and older.  Dividing the groups in this way significantly 
decreased the number of participants to compare. Nonetheless, seeing where groups 
struggled in terms of their performance was interesting. The older/focal group appeared 
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to do worse than the other three groups in regard to processing speed, visual spatial 
memory, inhibition, attention, visual-motor integration, and fine-motor skills, but all 
groups had below average fine-motor-skills functioning for the majority in the group. All 
other domains varied considerably across the groups. Because the sample size of the 
whole cohort was so small, these comparisons have to be viewed with caution. Although 
the older/focal group appeared to perform worse than the other groups, one should note 
that six or fewer individuals obtained a score on these variables. Therefore, the 
performances of these six individuals were likely not an accurate representation of the 
group.  
Years Post PRT  
Because years since PRT varied among the groups, the current study also 
investigated whether differences between groups were based on this concept (i.e., 3 years 
or fewer vs. 4 years or more). Descriptively, the groups performed in the Average range 
on verbal comprehension, perceptual reasoning, spatial visual memory, verbal memory, 
and visual attention and inhibition measured by a computerized assessment (i.e., CPT). 
Both groups performed in the Low Average range in regard to processing speed and in 
the Impaired range regarding dominant-hand fine-motor skills. The groups differed in 
terms of visual facial memory, visual-spatial integration, and auditory attention and 
inhibition skills.  
 These groups were relatively equal regarding number of participants (13 
individuals with 3 or fewer years since PRT vs. 11 individuals with 4 or more years since 
PRT). Additionally, the group with 3 or fewer years since PRT performed relatively 
better than the group that was 4 or more years post PRT. This finding is relatively 
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consistent with previous research in that the magnitude of deficits takes time to evolve 
(Hanzlik et al., 2015; Reeves et al., 2006). A closer look at the groups showed that the 
individuals with 3 or fewer years since PRT were older at diagnosis by 2 years, possibly 
also impacting mean performance. Additionally, the group 4 or more years post PRT had 
higher percentages of individuals with pre-existing conditions, posttreatment medical 
consequences, and/or mental-health diagnoses compared to the group with 3 or less years 
post PRT. This relative discrepancy is interesting because as neurocognitive deficits post 
PRT may take time to develop, does time also have a correlation with additional 
problems seen post PRT? Such problems as mental-health diagnoses may take time to 
develop in survivors of PBTs as they start to settle into their daily lives and have to learn 
to cope with the realities of their diagnosis and any treatment effects.  These 
characteristics, combined with lower mean age at diagnosis, possibly culminated into 
worse functioning on the few variables for the group with 4 or more years post PRT, in 
addition to varied performance between the groups overall.   
Gender  
Although the cohort in the current study was predominantly male, comparisons 
were made based on gender. Both male and female participants performed in the Average 
range in regard to verbal comprehension, perceptual reasoning, visual spatial memory, 
verbal memory, and visual inhibition and attention skills measured using a computerized 
assessment (i.e., CPT). Both groups performed in the Low Average range in regard to 
processing speed, and both groups performed in the Impaired range in regard to 
dominant-hand fine-motor skills. The groups varied considerably on the remaining 
variables, making difficult a determination regarding which group had better outcomes. 
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Previous research has shown female gender to be a risk factor for deficits in verbal and 
nonverbal IQ abilities following treatment for PBTs with conventional RT (Moore, 2005;  
Wefel, Noll, & Scheurer, 2016). However, this research apparently has been mixed 
(Olsson, Perrin, Lundgren, Hjorth, & Johanson, 2014). The results from the current study 
show that female individuals performed better on verbal IQ measures, but performed 
worse on nonverbal IQ measures. However, scores for both female and male participants 
were in the Average range for both domains. Therefore, the lack of differences between 
these groups may relate to larger number of male participants or to age; the male 
participants were younger and 3.53 years post PRT, while females were older (within a 
large range) and 4.4 years post PRT. The majority of male (73.7%) and female (80%) 
participants received focal PRT. Male participants also had higher percentages of pre- 
and posttreatment conditions, possibly impacting the group’s performance. Overall, 
making overarching conclusions using gender as a construct was difficult. Research on 
gender and PRT is lacking, so few previous studies were available for comparison.  
Preexisting Conditions 
 Lastly, mean performance was investigated using pre-existing conditions. Again, 
only four participants had one or more pre-existing conditions, but this comparison was 
completed to determine whether these conditions may have had an impact on 
performance overall. When comparing the groups, much like other comparisons, 
performance on many variables was in the Average range, and included verbal 
comprehension, perceptual reasoning, visual facial memory, contextual verbal memory, 
and visual attention skills. Processing speed was Low Average, and auditory inhibition 
was Borderline across groups.  Additionally, dominant-hand fine-motor skills were 
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Impaired across groups. Of note, the group with pre-existing conditions had a mean score 
almost 20 points below the group without these conditions in regard to fine-motor skills. 
Previous research has found an association with perioperative and operative factors, such 
as shunt infections, and poorer neuropsychological functioning, especially in regard to 
reduced hand skill (Fossati et al., 2009), possibly relating to the discrepancy in scores for 
fine-motor skills. Additionally, survivors of PBTs undergo many treatments, including 
surgery, chemotherapy, and/or radiation, as well as stem cell treatment and shunt 
placement for hydrocephalus. Additionally, posterior fossa syndrome (PFS) has the 
potential to emerge post surgery, affecting fine-motor skills, as well as cognitive abilities 
(Avula et al., 2015). These findings raise questions regarding the impact of already 
existing problems and the impact of surgery and treatment for survivors of PBTs.  
 Nonetheless, the group with pre-existing conditions appeared to perform worse on 
some variables compared to the group who did not have any pre-existing conditions. This 
group was older at diagnosis and at the most recent evaluation, received focal PRT, and 
was about 3 years post PRT. The impact of these characteristics is largely unknown 
because of such a small sample size. Interestingly, the group did not contain any 
individuals who had received a mental-health diagnosis or medical consequence post 
treatment for their PBTs. This discrepancy leads to questioning the utility of the current 
study hypothesizing if mental-health or medical consequences post treatment affects 
performance on the variables for this small sample. The completion of some kind of 
comparison using these variables as constructs to investigate would have been useful. 
However, the differences between functioning in these domains are so small that 
hypothesizing moderating variables for such discrepancies is impossible.  
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 Overall, no matter how the groups were divided, certain trends emerged. Verbal 
comprehension and perceptual reasoning were consistently in the Average range,  
consistent with previous research associating PRT with sparing of IQ abilities (Gondi et 
al., 2016; Ventura et al., 2018). Performance across the cohort also indicated Low 
Average functioning in regard to processing speed and Low Average or below 
functioning in regard to visual-motor integration. Again, these findings are consistent 
with other PRT research. Pulsifer et al. (2015) and Ventura et al. (2018) also found Low 
Average and declining processing speed at follow-up.  Additionally, visual-motor 
coordination differed from the normative mean in the group of individuals treated with 
craniospinal PRT for Antonini et al. (2017), consistent with current findings.  Fine-motor 
skills were consistently in the Impaired range across all groups in the current cohort. 
Although research investigating visual-motor/motor functioning and PRT is sparse, 
research with conventional RT has shown below-expected functioning in those domains 
(Bonner et al., 2009; Spiegler et al., 2004).   
Other domains were inconsistent in performance across the groups. Overall, 
research assessing PRT and attention and memory is lacking, making a comparison of the 
findings difficult. However, research in these domains with conventional RT has found 
higher errors of omissions and inhibition problems (De Ruiter et al., 2013; Winter et al., 
2014), consistent with current findings of Low Average or below performance on an 
inhibition variable (Test of Everyday Attention for Children [TEA-Ch] Walk, Don’t 
Walk) across all groups. However, results from the current study found relatively 
Average range performance on the CPT across all groups.  This is consistent with the 
findings of Antonini et al. (2017), with their group not differing from the normative mean 
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on any CPT-II variable. This finding is interesting, as scores on another measure 
investigating attention and inhibition varied greatly between groups in the current study.  
Children and adolescents possibly are more familiar with computers and possibly are 
more engaged when using them during testing. Therefore, performance on this particular 
measure is more intact compared to that on other measures of attention. Additionally, 
Omission Errors and Commission Errors are often used in research (De Ruiter et al., 
2013; Reeves et al., 2006), so another subtest might better capture performance in this 
domain. However, this task uses a visual cue, rather than an auditory cue, which is used 
in the other measures of attention and inhibition that were used in the study. Hearing loss 
is a common side effect of both chemotherapy and radiation. Therefore, hearing 
difficulties could be a reason behind better visual attention and inhibition abilities 
compared to auditory attention and inhibition abilities for the individuals in the present 
study.  
Additionally, below-average verbal-memory skills have been found following 
conventional RT (Mulhern et al., 2001; Reddick et al., 2003; Reeves et al., 2006). 
Performance on verbal list learning ranged from Impaired to Average across groups in 
the current study, while contextual verbal memory was consistently in the Average range 
across all groups. Zureick et al. (2018) also found contextual verbal memory to be within 
the normal range for their group treated with PRT.  
In conclusion, this study found areas of functioning that were consistently intact 
(i.e., VCI, PRI). These results make sense in terms of tumor location for the cohort and 
expectations post treatment for a PBT. VCI and PRI are measures of crystallized 
knowledge and, therefore, should not be greatly affected by surgery or treatment of an 
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infratentorial tumor. Additionally, research consistently indicates preservation of these 
skills. Of course, exceptions are possible when the person is extremely young when 
receiving treatment, as were participants in this cohort. Eight participants were 4 years 
old or younger at time of diagnosis. The good news is that these individuals’ 
performances appear to remain largely intact at an average of 3.7 years post PRT, despite 
their young age.  
In regard to areas that were consistently below expected age norms (Processing 
Speed Index [PSI], Purdue Pegboard, Beery VMI), these findings also make sense 
regarding the location of an infratentorial tumor. Because these tumors are located near 
the cerebellum, an area of the brain responsible for many functions, including motor 
functions, skills needed for the measures just stated rely on some kind of motor 
functioning.  Therefore, surgery and treatment to this area would most likely result in 
impaired functioning regarding fine-motor skills. However, because surgical removal of a 
tumor alone has been correlated with poor fine-motor skills (Fossati et al., 2009; 
Levisohn et al., 2000), determining whether surgery or PRT to that area of the brain 
related to functioning below expected means in the current study is difficult. 
Additionally, the synergistic properties of surgery, possible PFS, and PRT are unknown, 
as performance on the variables in the current study was post surgery and PRT.  
Owing to extreme variability on other variables, determining the effect of PRTs 
on neuropsychological functioning is difficult for this cohort. Many possible moderating 
variables (e.g.., pre-existing conditions, years since PRT) could have affected findings. 
Unfortunately, the sample size was too small to significantly ascertain the impact of these 
moderating variables. Furthermore, the impact of recurrence could not be investigated. 
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The individual who was retreated with craniospinal PRT was very young at diagnosis 
(i.e., 3 years old) and had received focal PRT for the original tumor. The other individual 
(3 years old) who had recurrence was treated with surgery and chemotherapy only and 
had received focal PRT for the original tumor. The impact of recurrence and subsequent 
treatment is largely unknown because of the small sample size in the current study. 
Investigating the data for these two individuals did show that the individual retreated with 
craniospinal PRT performed worse compared to the individual who was retreated with 
chemotherapy only. This finding is, of course, not a statistically significant difference, 
but this type of difference would be expected, as craniospinal PRT is a risk factor for 
neurocognitive deficits.  
Correlations  
In addition to looking at group differences, correlational analyses indicated that 
certain variables were correlated with others. For example, a correlation was found 
between VCI and PRI, suggesting the two indices are measuring aspects of the same 
domain – cognitive functioning. This correlation aligns with the four-factor model that is 
set forth from the standardized factor loadings used in confirmatory factor analysis from 
the Wechsler scales (Wechsler, 2008). Thus, the indices of the Wechsler Adult 
Intelligence Scale – Fourth Edition (WAIS-IV) are correlated with the FSIQ, which 
relates to the g-factor of intelligence. Thus, the correlations found in the current study 
help to reiterate this relationship.  
Furthermore, time since PRT was controlled for with these correlations. When 
time was controlled, all relationships remained except between VCI and PRI. Therefore, 
at some point in time, performances on these variables became dissimilar and were no 
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longer correlated. Parsing out performance on these measures would be interesting to 
help in determining which developmental factors obscure existing relationships between 
factors at some points and not others.    
 Additionally, correlations were determined between PSI, Purdue Pegboard -  
Dominant, and Beery VMI. These correlations are interesting because all three, although 
testing slightly different domains, have one skill in common: fine-motor skills. 
Additionally, these correlations remained when time since PRT was controlled. 
Therefore, the performances on these variables remain related as time goes on.  
Implications 
 The results of the current study highlight the potential effectiveness of PRT for 
children and adolescents diagnosed with an infratentorial brain tumor. Results 
consistently showed a general sparing of cognitive functioning (VCI, PRI) with Low 
Average processing speed and visual perceptual abilities, and Impaired fine-motor skills 
for the dominant hand. Although this study was descriptive in nature, the overall findings 
indicate that PRT may spare neuropsychological functioning, thereby correlating with 
previous research. The areas in which below-average functioning occurred, such as 
processing speed, have been related to damage to white-matter networks in the brain (De 
Ruiter et al., 2013; Mabbott et al., 2008; Nelson et al., 2013; Palmer et al., 2013; Reddick 
et al., 2003; Reddick et al., 2014).   
Although this study did not look at academic functioning, the domains assessed 
certainly affect one’s ability to perform academically. Because children and adolescents 
who suffer from PBTs often fall behind academically, learning where difficulties lie for 
child and adolescent survivors of brain tumors helps with interventions used after 
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treatment (Butler et al., 2008; Mabbott et al., 2008; Reeves et al., 2006). Additionally, 
when the child is ready to reintegrate into school, ensuring the school fully understands 
the extent of deficits the survivor may have and how to accommodate them in the school 
setting would be important. Results from the current study show that survivors of PBTs 
may need assistance with aspects of school associated with slow processing speed and 
impaired fine-motor skills. Assessment of visual and memory skills, as well as 
attention/executive functioning, would be important, as these skills apparently are 
differentially affected.  Furthermore, participants in this cohort received diagnoses of 
language disorders, learning disorders, and intellectual disabilities; accommodating and 
intervening for these issues would also be important.  
Qualitative research has indicated that teachers would like more information 
regarding the condition of the PBT and how it relates to support given to the child at 
school and possibly unrealistic expectations from involvement from parents (Vanclooster 
et al., 2017). In the majority of cases, little communication occurred between school and 
healthcare providers, a situation that affects the teacher’s knowledge about the child’s 
condition and trajectory of deficits that may be possible. The different ways school and 
healthcare professionals accept information from each other can negatively impact 
collaborations (Vanclooster et al., 2017). Therefore, communication among all 
individuals involved in a survivor’s life would be important, as would educating teachers 
and schools on conditions and expectations as time goes on for these individuals (Nathan 
et al., 2007; Vanclooster et al., 2017). Difficulties may not be as evident when children 
go back to school if they are in primary grades, but as the demands of school become 
higher in middle and high school, the survivor would likely continue to need 
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accommodations, a situation poorly understood by schools (Nathan et al., 2007). 
Working with the school counselor or director of special education would be beneficial. 
Furthermore, working with college administrations would be important as the survivor 
goes beyond high school (Nathan et al., 2007).  
The current study also raises awareness regarding the importance of advocacy for 
survivors of PBTs. An enhanced understanding of difficulties these survivors face after 
treatment helps to inform the design and implementation of such interventions just 
discussed. Additionally, this understanding may also enhance utility of cognitive-
rehabilitation programs with survivors. Lastly, having an advocate for the survivor would 
be most important to help him or her and associated family members navigate through the 
school system, as well as other resources that may be available. Physicians and other 
healthcare providers could educate schools and teachers on the survivor’s condition, on 
any accommodations that would be helpful, and on the importance of repeat evaluation to 
monitor the individual’s neurocognitive functioning over time. If, for some reason, 
parents encounter barriers with the school system and the provision of appropriate 
accommodations, they should be encouraged to educate themselves about their legal 
rights and possibly obtain a legal advocate, as three federal laws provide protection of 
rights for those with mental and/or physical limitations (Nathan et al., 2007).  
In addition to academic functioning and the correlated accommodations and/or 
interventions that would be helpful for the survivors of PBTs, mental-health concerns 
cannot be ignored. In the current study, a total of 10 (41.7%) participants were diagnosed 
with a mental-health disorder post diagnosis and treatment. Among these diagnoses were 
posttraumatic stress disorder, depression, and anxiety. Although the sample size was 
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small, more than one third of these children and adolescents would need some kind of 
intervention post treatment. Knowing that these survivors of PBTs are at risk for these 
mental-health concerns helps treatment providers be cognizant of the problems and 
hopefully integrate screening tools into the survivors’ appointments.  Screening for 
mental health concerns does not have to be done by a psychologist or neuropsychologist; 
any treatment provider should be screening for mental-health symptoms. Additionally, 
training providers on the prevalence of these concerns and how to help when a screener 
comes back positive for a possible mental-health disorder, such as by contacting a 
mental-health provider in the hospital, would be important.  
Limitations 
 This study is not without limitations. The major and most important limitation of 
this study is the small sample size (n = 24). Because the sample size was so small, there 
was not enough adequate power for statistical analyses. Therefore, testing the hypotheses 
as planned was impossible. Thus, whether age has an effect on neuropsychological 
functioning for these survivors of PBTs is unclear.  
In addition to small sample size, dividing the cohort using different constructs 
resulted in unequal groups, which made comparing the group performances difficult 
because of many possible confounding variables. Additionally, the impact of group 
characteristics on results cannot be ignored. This group was heterogeneous in terms of 
tumor type, PRT dose, and pre-existing conditions, to name a few characteristics. The 
majority of the sample was diagnosed with ependymoma (anaplastic included) followed 
by medulloblastoma, and PRT dose ranged from 3000 cGy to 5940 cGy, with the 
majority of the sample receiving 5400 cGy. This male-dominant group underwent 
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resection of their tumors (100%), and the majority was treated with chemotherapy 
(66.7%) in addition to PRT. The average age at diagnosis was 7.8 years, and the average 
follow-up years since treatment was approximately 4. Additionally, a number of pre-
existing conditions (e.g., prematurity, perinatal intraventricular hemorrhage, ASD, mild 
hypoxia at birth, attention deficit/hyperactivity disorder [ADHD]). Overall, any effect of 
PRT dose, PRT volume, gender, or use of chemotherapy on results for this group was 
difficult to ascertain. Although many hypotheses were identified regarding performance, 
differences based on age or gender was difficult to ascertain. Therefore, any below-
average score at follow-up may be the result of the treatment itself or of another variable 
(i.e., premorbid functioning).  Furthermore, three participants had recurrence of their 
tumor. Although only one was retreated with cranial PRT, the other two were treated with 
surgery, chemotherapy, and/or spinal radiation. The impact of those treatments in 
addition to the original treatment is largely unknown, especially for this small sample 
group.   
Although this study is a great start to developing hypotheses and trends in 
functioning for survivors of infratentorial brain tumors, a larger sample size is needed to 
determine the true impact of PRT on neuropsychological functioning for these survivors.   
Additionally, small sample size affects the generalizability of findings to other groups of 
survivors of PBTs. The current study focused upon infratentorial tumors because of their 
higher incidence and higher morbidity, so these results cannot be generalized for tumors 
in other locations.  Furthermore, although the participants in the current study were 
approximately 4 years post treatment, the deficits or difficulties might not have been 
evident yet and could emerge over time.  
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Another limitation includes the fact that this study used an archival data set; 
therefore, missing data were impossible to obtain. If a participant could not complete a 
task because of effort concerns or ability level, he or she did not obtain a score for that 
task. Therefore, that individual would have missing data and be unable to be included 
into analysis for that particular domain. Because the sample size is small as is, having 
missing scores makes analysis even more difficult. Additionally, because this study 
looked at functioning over time, participants became older and/or had to be switched to 
another version of a test (e.g., CVLT-C to CVLT-II) or test versions changed (e.g., 
WISC-IV to WISC-V). Therefore, scores for these domains were combined to make one 
variable for analysis. The effect of doing so, if any, on the analysis of the sample is 
unclear. However, test change can introduce different questions and question style, thus 
potentially affecting scores over time.  
Lastly, the inclusion criteria were broadly interpreted when including one 
participant who was diagnosed and treated with PRT for a nongerminous germ cell 
tumor. This tumor originated in the supratentorial area of the brain and extended into the 
posterior fossa. Because the tumor extended into the infratentorial region, this person was 
kept in the study.  
Future Directions 
 Future directions for this type of research include the use of a control or 
comparison group, although doing so is likely not feasible. This study was unable to have 
a control group at the time of analysis, but a control group is essential to understanding 
whether PRT truly reduces morbidity compared to conventional RT for those with PBTs. 
Additionally, future studies should use a longitudinal design in which data for both 
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baseline and multiple follow-ups are included to help determine treatment effects as time 
progresses. Most recent research with PRT has shown study cohorts that were about 2 to 
3 years post PRT, on average. Although number of years to wait for follow-up has not 
been suggested, longer follow-up beyond 2 to 3 years is thought necessary to fully 
understand the impact of PRT on neurocognitive functioning, as some deficits after 
treatment take time to evolve (Hanzlik et al., 2015; Reeves et al., 2006; Spiegler et al., 
2004). Longer follow-up would likely allow researchers to determine the point at which 
these deficits emerge and the point at which age makes an impact on functioning. These 
questions would be interesting to answer and would be extremely helpful for this 
population.  
 Additionally, because much research discusses the fact that lower-than-expected 
functioning likely relates to the reduced rate of skill acquisition compared to that of 
peers, future studies could include raw scores into analyses. If previous research is true, 
raw scores should remain relatively consistent or possibly increase as the survivor gets 
older. This information would help in determining when survivors’ skill levels become 
comparable to those of peers. Future research should also include the possible effects of 
moderating variables, such as pre-existing mental-health conditions or medical 
consequences post PRT. Additionally, looking at differences in individuals treated with 
and without chemotherapy would be interesting. 
Future studies should also ensure a standardized battery and follow-up procedures 
for the participants. Understandably, this is difficult because of attrition rates and 
neuropsychological functioning at the time of follow-up, but standardized practices could 
decrease the number of potential confounding variables. Additionally, future studies 
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should encompass additional domains. Most research, thus far, has focused on cognitive 
functioning, thus leaving out many domains, such as memory, executive functioning, and 
social cognition.  Investigating all domains of neuropsychological functioning is 
important in order to assist in intervention use. For example, more research to assess 
moderating variables (e.g., pre-existing conditions, time since PRT) is needed to 
determine the relationship of these deficits to different neuropsychological functioning 
abilities post treatment. Additionally, more in-depth research investigating domains 
would be beneficial. Understanding the breakdown of memory (i.e., encoding vs. 
retrieval) would be beneficial for treatment interventions and school accommodations.   
Lastly, adding self-reports from parents and teachers can be helpful to evaluate 
how others see these deficits, as well as to evaluate social-emotional functioning and 
quality of life for these patients. Understanding the impact of these characteristics on 
functioning would also be interesting to investigate and would add to the body of 
literature.  
Conclusion 
 This study set out to determine the effect of age at diagnosis on 
neuropsychological functioning for survivors of infratentorial PBTs treated with PRT. 
The small sample size prevented the use of multivariate analyses to test the hypotheses 
set, unfortunately. Therefore, a more descriptive approach was used to explain the cohort 
by age, PRT volume, follow-up time, gender, and pre-existing conditions. Overall, most 
domains assessed ranged from Low Average to Average, with much variability.  Across 
all groups, verbal comprehension and perceptual reasoning skills were in the Average 
range, and processing speed was in the Low Average range. Fine-motor skills were 
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Impaired across all groups. A number of participants received a mental-health diagnosis 
post treatment, along with significant medical consequences. Overall, these results help 
add to the limited research on survivors of PBTs treated with PRT. Additionally, the 
results can help to establish appropriate interventions and accommodations for this 
population.   
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Appendix  
Standard Score Percentile Rank Scaled Score ETS Score T-Score Z-Score Description 
150 >99.9     Very Superior 
149 >99.9     Very Superior 
148 99.9     Very Superior 
147 99.9     Very Superior 
146 99.9     Very Superior 
145 99.9 19 800 80 +3.0 Very Superior 
144 99.8     Very Superior 
143 99.8     Very Superior 
142 99.7  775 78 +2.75 Very Superior 
141 99.7     Very Superior 
140 99.6 18 767 77 +2.67 Very Superior 
139 99.5     Very Superior 
138 99     Very Superior 
137 99  750 75 +2.50 Very Superior 
136 99     Very Superior 
135 99 17 733 73 +2.33 Very Superior 
134 99     Very Superior 
133 99  725 72 +2.25 Very Superior 
132 98     Very Superior 
131 98     Very Superior 
130 98 16 700 70 +2.00 Very Superior 
129 97     Superior 
128 97  675 68 +1.75 Superior 
127 96     Superior 
126 96     Superior 
125 95 15 667 67 +1.67 Superior 
124 95     Superior 
123 94  650 5 +1.50 Superior 
122 93     Superior 
121 92     Superior 
120 91 14 633 63 +1.33 High Average 
119 90     High Average 
118 88  325 62 +1.25 High Average 
117 87     High Average 
116 86     High Average 
115 84 13 600 60 +1.00 High Average 
114 82     High Average 
113 81  575 58 +0.75 High Average 
112 79     High Average 
111 77     High Average 
110 75 12 567 57 +0.67 Average 
109 73     Average 
108 70  550 55 +0.55 Average 
107 68     Average 
106 66     Average 
105 63 11 533 533 +0.33 Average 
104 61     Average 
103 58     Average 
102 55  525 52 +0.25 Average 
101 53     Average 
100 50 10 500 50 0.00 Average 
99 47     Average 
98 45  480 48 -0.25 Average 
97 42     Average 
96 40     Average 
95 37 9 467 47 -0.33 Average 
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94 34     Average 
93 32  450 45 -0.50 Average 
92 30     Average 
91 27     Average 
90 25 8 433 43 -0.67 Average 
Standard Score Percentile Rank Scaled Score ETS Score T-Score Z-Score Description 
89 23     Low Average 
88 21  425 42 -0.75 Low Average 
87 19     Low Average 
86 18     Low Average 
85 16 7 400 40 -1.00 Low Average 
84 14     Low Average 
83 13  375 38 -1.25 Low Average 
82 12     Low Average 
81 10     Low Average 
80 9 6 367 37 -1.33 Low Average 
79 8     Borderline 
78 7  350 35 -1.50 Borderline 
77 6     Borderline 
76 5     Borderline 
75 5 5 333 33 -1.67 Borderline 
74 4     Borderline 
73 4  325 32 -1.75 Borderline 
72 3     Borderline 
71 3     Borderline 
70 2 4 300 30 -2.00 Borderline 
69 2     Impaired 
68 2  275 28 -2.25 Impaired 
67 1     Mild (69-55) 
66 1     Mild (69-55) 
65 1 3 267 27 -2.33 Moderate (54-40) 
64 1     Moderate (54-40) 
63 1  250 25 -2.50 Severe (39-25) 
62 1     Severe (39-25) 
61 0.5     Profound (<25) 
60 0.4 2 233 23 -2.67 Profound (<25) 
59 0.3     Profound (<25) 
58 0.2  225 22 -2.75 Profound (<25) 
57 0.1     Profound (<25) 
56 0.1     Profound (<25) 
55 0.1 1 200 20 -3.00 Profound (<25) 
54 0.1     Profound (<25) 
53 0.1     Profound (<25) 
52 0.1     Profound (<25) 
51 <0.1     Profound (<25) 
50 <0.1     Profound (<25) 
